Cardio Flashcards

1
Q

What are the shockable rhythms

A

ventricular fibrillation/pulseless ventricular tachycardia (VF/pulseless VT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the non shockable rhythms

A

asystole/pulseless-electrical activity (asystole/PEA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what do you do when you defibrillate (how many shocks etc)

A

single shock for VF/pulseless VT followed by 2 minutes of CPR
or three successive shocks if the patient is a ‘monitored patient’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When do you give adrenaline in a cardiac arrest

A

1mg asap for non shockable rhythms
during VF/VT, 1mg given once chest compressions have restarted after third shock
repeat adrenaline every 3-5mins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

when do you give amiodarone in cardiac arrest

A

300mg for patients in VF/pulseless VT after 3 shocks
further dose of 150g after 5 shocks
lidocaine can be used as an alternative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

when do you use thrombolytic drugs in cardiac arrest

A

if PE is suspected
give alteplase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the reversible causes of cardiac arrest

A

The ‘Hs’
Hypoxia
Hypovolaemia
Hyperkalaemia, hypokalaemia, hypoglycaemia, hypocalcaemia, acidaemia and other metabolic disorders
Hypothermia

The ‘Ts’
Thrombosis (coronary or pulmonary)
Tension pneumothorax
Tamponade - cardiac
Toxins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Person has cardiac arrest with shockable rhythm, what do you do

A

CPR 30:2
attach defib
assess rhythm
1 shock
continue CPR for 2 mins
reassess rhythm
repeat
3 shocks -> 1mg adrenaline,300mg amiodarone
5 shocks -> 150mg amiodarone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Person has cardiac arrest with non-shockable rhythm, what do you do

A

1mg adrenaline
resume CPR for 2 mins
reassess rhythm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does a raised troponin level in the context of chest pain suggest

A

MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the difference between unstable angina and NSTEMI

A

no elevation of troponin
however, troponin may take a few hours to rise so treated the same until known

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are classic symptoms of ACS

A

chest pain (central/left sided)
radiates to jaw or left arm
described as heavy, ‘like an elephant on my chest’
dyspnoea
sweating
nausea and vomiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What investigations do we do for chest pain

A

ECG
cardiac markers eg troponin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What ECG changes are linked to anterior STEMI and what artery

A

V1-V4 left anterior descending

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What ECG changes are linked to inferior STEMI and what artery

A

II, III, aVF right coronary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What ECG changes are linked to lateral STEMI and what artery

A

I, V5-V6 left circumflex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

how do you treat ACS generally

A

in general = MONA:
morphine, oxygen, nitrates, aspirin

If NSTEMI, use risk tool eg GRACE to determine management, if high risk/unstable, do coronary angiography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is secondary prevention of ACS

A

aspirin
a second antiplatelet if appropriate (e.g. clopidogrel)
a beta-blocker
an ACE inhibitor
a statin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are features of hypercalcaemia

A

‘bones, stones, groans and psychic moans’
corneal calcification
shortened QT interval on ECG
hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what can cause a prolonged QT interval

A

Drugs
amiodarone, sotalol, class 1a antiarrhythmic drugs
tricyclic antidepressants, fluoxetine
chloroquine
terfenadine
erythromycin

Other
electrolyte: hypocalcaemia, hypokalaemia, hypomagnesaemia
acute myocardial infarction
myocarditis
hypothermia
subarachnoid haemorrhage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How do you treat VT/TdP

A

(in TdP) IV mag sulph first line to stabilise cardiac membrane

amiodarone

If drug therapy fails
electrophysiological study (EPS)
implant able cardioverter-defibrillator (ICD) - this is particularly indicated in patients with significantly impaired LV function

Give shock if unstable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What ECG changes are linked to posterior STEMI and what artery

A

V1-V3
Reciprocal changes of STEMI are typically seen:
horizontal ST depression
tall, broad R waves
upright T waves
dominant R wave in V2

Posterior infarction is confirmed by ST elevation and Q waves in posterior leads (V7-9)

Usually left circumflex, also right coronary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

‘widened QRS complexes and a notched morphology of the QRS complexes in the lateral leads’ what is it

A

left bundle branch block, prompts investigation for ACS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

‘Delta waves and a short PR-interval’

A

Wolff-Parkinson-White syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
'New widening QRS complexes and an RSR' pattern in V1'
right bundle branch block
26
'T-wave flattening and the appearance of U-waves'
hypokalaemia
27
what is acute management of heart failure
IV loop diuretics e.g. furosemide or bumetanide oxygen can give nitrates if concomitant myocardial ischaemia, severe hypertension or regurgitant aortic or mitral valve disease with resp failure -> CPAP if hypotensive -> inotropic agents eg dobutamine mechanical circulatory assistance e.g. intra-aortic balloon counterpulsation or ventricular assist devices
28
when should you stop beta blockers for heart failure
heart rate less than 50 beats per minute, second or third degree atrioventricular block, or shock
29
how do you manage VTE/PE
massive PE + unstable -> alteplase otherwise -> DOAC (apixaban or rivaroxaban) if significant renal impairment -> LMWH, unfractionated heparin or LMWH followed by vitamin K antagonist eg warfarin if antiphospholipid syndrome -> LMWH followed by VKA
30
how long do you stay on anticoagulation for VTE/PE
If provoked, stop after 3 months (3-6 months if cancer) if unprovoked, go up to 6 months
31
how do you manage broad complex tachycardia
Regular assume ventricular tachycardia (unless previously confirmed SVT with bundle branch block) loading dose of amiodarone followed by 24 hour infusion Irregular seek expert help. Possibilities include: atrial fibrillation with bundle branch block - the most likely cause in a stable patient atrial fibrillation with ventricular pre-excitation torsade de pointes
32
how do you manage narrow (<0.12s) complex tachycardia
Regular vagal manoeuvres followed by IV adenosine if the above is unsuccessful consider a diagnosis of atrial flutter and control rate (e.g. beta-blockers) Irregular probable atrial fibrillation if onset < 48 hr consider electrical or chemical cardioversion rate control: beta-blockers are usually first-line unless there is a contraindication
33
What are side effects of loop diuretics
hypotension hyponatraemia hypokalaemia, hypomagnesaemia hypochloraemic alkalosis ototoxicity hypocalcaemia renal impairment (from dehydration + direct toxic effect) hyperglycaemia (less common than with thiazides) gout
34
what is stage 1 hypertension defined as?
Clinic BP >= 140/90 mmHg and subsequent ABPM daytime average or HBPM average BP >= 135/85 mmHg
35
36
what is stage 2 hypertension defined as?
Clinic BP >= 160/100 mmHg and subsequent ABPM daytime average or HBPM average BP >= 150/95 mmHg
37
what is stage 3 hypertension defined as?
Clinic systolic BP >= 180 mmHg, or clinic diastolic BP >= 120 mmHg
38
When do you treat hypertension
>=135/85 - only if they are <80 and have one of: -target organ damage -established cardiovascular disease -renal disease -diabetes -10 year cardiovascular risk >=10% >=150/95 - always treat
39
how do you manage hypertension
lifestyle advice: -low salt diet <6g a day ideally 3g -reduce caffeine intake -stop smoking etc If <55 or T2DM start with ACEi or ARB then add CCB or thiazide like diuretic then add both then if K+<4.5 add low dose spironolactone, if >4.5 add alpha or beta blocker If >55 and no T2DM or african/afro caribbean start with CCB add ACEi/ARB or thiazide like diuretic then add both then if K+<4.5 add low dose spironolactone, if >4.5 add alpha or beta blocker
40
What are blood pressure targets
<80 clinic=140/90, ABPM/HBPM = 135/85 >80 clinic=150/90, ABPM/HBPM = 145/85
41
What is CHA2DS2-VASc scoring system
Used to determine the need to anticoagulate a patient in atrial fibrillation
42
What is NYHA scoring system
Heart failure severity scale
43
DAS28
Measure of disease activity in rheumatoid arthritis
44
Child-Pugh classification
A scoring system used to assess the severity of liver cirrhosis
45
Wells score
Helps estimate the risk of a patient having a deep vein thrombosis
46
MMSE
Mini-mental state examination - used to assess cognitive impairment
47
HAD
Hospital Anxiety and Depression (HAD) scale - assesses severity of anxiety and depression symptoms
48
PHQ-9
Patient Health Questionnaire - assesses severity of depression symptoms
49
GAD-7
Used as a screening tool and severity measure for generalised anxiety disorder
50
Edinburgh Postnatal Depression Score
Used to screen for postnatal depression
51
SCOFF
Questionnaire used to detect eating disorders and aid treatment
52
AUDIT, CAGE, FAST
Alcohol screening tool
53
CURB-65
Used to assess the prognosis of a patient with pneumonia
54
Epworth Sleepiness Scale
Used in the assessment of suspected obstructive sleep apnoea
55
IPSS
International prostate symptom score
56
Gleason score
Indicates prognosis in prostate cancer
57
APGAR
Assesses the health of a newborn immediately after birth
58
Bishop score
Used to help assess the whether induction of labour will be required
59
Waterlow score
Assesses the risk of a patient developing a pressure sore
60
FRAX
Risk assessment tool developed by WHO which calculates a patients 10-year risk of developing an osteoporosis related fracture
61
Ranson criteria
Acute pancreatitis scoring system
62
MUST
Malnutrition scoring system
63
What are features of complete heart block
syncope heart failure regular bradycardia (30-50 bpm) wide pulse pressure JVP: cannon waves in neck variable intensity of S1
64
What is first degree heart block
PR interval > 0.2 seconds
65
What is second degree heart block
type 1 (Mobitz I, Wenckebach): progressive prolongation of the PR interval until a dropped beat occurs type 2 (Mobitz II): PR interval is constant but the P wave is often not followed by a QRS complex
66
What is third (complete) degree heart block
there is no association between the P waves and QRS complexes
67
infarction of what vessel can cause complete heart block post MI
right coronary artery
68
How do you manage STEMI
If STEMI, aspirin 300mg percutaneous coronary intervention (PCI) if presenting <12 hours and can be given within 120 mins of the time that fibrinolysis can be given (basically you want to give PCI but would consider fibrinolysis if you cant give it in time. if fibrinolysis, also give antithrombin drug and do ECG after 60-90 mins to see if changes have resolved) PCI is given with drug eluting stent through radial access preferred over femoral During PCI, unfractionated heparin with bailout glycoprotein IIb/IIIa inhibitor (GPI) is given second antiplatelet should be given with aspirin eg clopidogrel (if taking oral anticoagulant), prasugrel (if not taking oral anticoagulant)
69
How do you manage NSTEMI
aspirin + fondaparinux (if no immediate PCI) estimate 6 month mortality eg GRACE low risk (<3%) - ticagrelor or clopidogrel (if high risk of bleeding) higher risk (>3%) - Offer PCI (immediately if unstable otherwise within 72 hours) give prasugrel or ticagrelor give unfractionated heparin
70
how do you treat bradycardia
IV atropine 5oomcg then use again up to 3mg then transcutaneous pacing then isoprenaline/adrenaline infusion then transvenous pacing with specialist
71
what are side effects of ACEi
cough angioedema hyperkalaemia first dose hypokalaemia
72
what are some cautions and contraindications for ACEi
pregnancy and breastfeeding - avoid renovascular disease - may result in renal impairment aortic stenosis - may result in hypotension hereditary of idiopathic angioedema
73
what electrolytes change when using an ACEi
creatinine potassium
74
what is an acceptable change for creatinine/potassium when using ACEi
acceptable changes are an increase in serum creatinine, up to 30% from baseline and an increase in potassium up to 5.5 mmol/l.
75
what condition can using an ACEi with result in significant renal impairment
bilateral renal artery stenosis
76
how would you manage angina pectoris
aspirin + statin for every patient sublingual glyceryl trinitrate to abort angina attacks beta blocker/CCB first line - if CCB used solely, a rate limiting one such as verapamil or diltiazem should be used - if used in combo, use a longer acting dihydropyridine CCB eg amlodipine, modified release nifedipine if poor response, increase to max tolerated dose if still symptomatic after monotherapy add the other thing (ie CCB/beta blocker) then if still symptomatic add one of long acting nitrate ivabradine nicorandil ranozaline
77
How do people using nitrates avoid nitrate tolerance
use an assymetric dosing interval if using standard release isosorbide mononitrate which allows a daily nitrate free time of 10-14 hours
78
what are features of acute pericarditis
chest pain: may be pleuritic. Is often relieved by sitting forwards other symptoms include a non-productive cough, dyspnoea and flu-like symptoms pericardial rub
79
what do you see on ECG for acute pericarditis
widespread changes 'saddle shaped' ST elevation PR depression (most specific for acute pericarditis)
80
what investigations would you do for acute pericarditis
ECG transthoracic echocardiography bloods - inflam markers, troponin for possible myopericarditis
81
how do you manage acute pericarditis
mainly outpatients unless fever >38 or high troponin treat underlying cause avoid physical activity combination of NSAID and colchicine used until symptoms go or inflam markers go down followed by tapering of dose
82
what is mitral stenosis
describes the obstruction of blood flow across the mitral valve from the left atrium to the left ventricle leading to increased pressure within the left atrium, pulmonary vasculature and right side of the heart
83
what causes mitral stenosis
rheumatic fever
84
what are features of mitral stenosis
dyspnoea - increased left atrial pressure -> pulmonary venous hypertension haemoptysis mid-late diastolic murmur (best heard on expiration) loud S1 opening snap - indicates mitral valve leaflets are still mobile low volume pulse malar flush atrial fib - secondary to increased left atrial pressure -> left atrial enlargement when severe - length of murmur increases, opening snap becomes closer to S2
85
what do you see on xray of mitral stenosis
possible left atrial enlargement
86
how do you manage mitral stenosis
asymptomatic - monitor symptomatic - percutaneous mitral balloon valvotomy, mitral valve surgery associated aFib - require anticoagulation - usually warfarin
87
how do you deal with severe airway obstruction (emergency setting)
give up to 5 back blows give up to 5 abdominal thrusts (pressing forcibly into the upper abdominal area with an upward moment) keep continuing above cycle
88
What is the pulmonary embolism rule out criteria (PERC)
you do it when you have a low suspicion (<15% probability) of PE but just want reassurance. All criteria must be negative to rule it out negative test reduces probability to <2%
89
What is the 2 level Wells score and how do you manage the patient
you do it if PE is suspected >4 points means its likely, <4 means unlikely if likely arrange immediate CTPA if there is a delay in doing this then interim anticoagulation should be given (DOAC) if positive result, PE confirmed if negative, consider proximal leg vein US scan if DVT expected If unlikely arrange a D dimer test if positive arrange immediate CTPA (give anticoag if delay) If negative, PE is unlikely so stop anticoags and consider an alternative diagnosis
90
When would you do V/Q scan over CTPA
if there is renal impairment
91
What ecg changes could you see in PE
S1Q3T3 - large S wave in lead I, a large Q wave in lead III and an inverted T wave in lead III (RARE) RBBB and right axis deviation sinus tachycardia
92
What xray changes do you see in PE
usually normal but could see wedge shaped opacification
93
how do you investigate chronic heart failure
first line - N-terminal pro-B-type natriuretic peptide (NT-proBNP) blood test if high (>2000pg/ml) - arrange specialist assessment including transthoracic echo within 2 weeks if raised (400-2000 pg/ml) do the same within 6 weeks if levels are 'high' arrange specialist assessment (including transthoracic echocardiography) within 2 weeks if levels are 'raised' arrange specialist assessment (including transthoracic echocardiography) echocardiogram within 6 weeks
94
how do you decide whether to use anticoagulation for aFib
use CHA2DS2-VASc score C Congestive heart failure 1 H Hypertension (or treated hypertension) 1 A2 Age >= 75 years 2 Age 65-74 years 1 D Diabetes 1 S2 Prior Stroke, TIA or thromboembolism 2 V Vascular disease (including ischaemic heart disease and peripheral arterial disease) 1 S Sex (female) 1 0 = no treatment 1 = males - consider treatment, females no >=2 = offer anticoag if no treatment, do transthoracic echo to exclude valvular heart disease Use DOACs, warfarin second line
95
what is atrial flutter and what do you see
a succession of rapid atrial depolarisation waves. 'sawtooth appearance'
96
how do you manage atrial flutter
radiofrequency ablation of the tricuspid valve isthmus is curative
97
what is the triad for cardiac tamponade + what are other features
Becks Triad: hypotension raised JVP muffled heart sounds dyspnoea tachycardia absent Y decent on JVP pulsus paradoxus - abnormally large drop in BP during inspiration electrical alternans on ECG
98
What are the differences between cardiac tamponade and constrictive pericarditis
1) JVP CT = Absent Y descent CP = X + Y present 2) Pulsus paradoxus CT = Present CP = Absent 3) Kussmaul's sign CT = Rare CP = Present 4) Characteristic features CP = Pericardial calcification on CXR
99
how do you manage cardiac tamponade
urgent pericardiocentesis (pericardial needle aspiration)
100
what are features of takayasu's arteritis
systemic features of a vasculitis e.g. malaise, headache unequal blood pressure in the upper limbs carotid bruit and tenderness absent or weak peripheral pulses upper and lower limb claudication on exertion aortic regurgitation (around 20%)
101
What other condition is takayasu's arteritis associated with
renal artery stenosis
102
how do you investigate takayasu's arteritis
magnetic resonance angiography (MRA) or CT angiography (CTA)
103
how do you manage takayasu's arteritis
steroids
104
What ecg changes do we see with hypothermia
bradycardia 'J' wave (Osborne waves) - small hump at the end of the QRS complex first degree heart block long QT interval atrial and ventricular arrhythmias
105
what are features of buergers disease
Young male smoker with symptoms similar to limb ischaemia - think Buerger's disease extremity ischaemia intermittent claudication ischaemic ulcers superficial thrombophlebitis Raynaud's phenomenon
106
what are features of tension pneumothorax
Severe respiratory distress, tracheal deviation, unilateral absent breath sounds, and haemodynamic instability
107
what are features of hypokalaemia
U waves small or absent T waves (occasionally inversion) prolong PR interval ST depression long QT
108
what is aortic regurgitation
leaking of aortic valve causing blood flow in reverse direction during ventricular diastole caused by aortic root disease or valve disease
109
what are acute valvular causes of aortic regurg
infective endocarditis
110
what are chronic valvular causes of aortic regurg
rheumatic fever: the most common cause in the developing world calcific valve disease connective tissue diseases e.g. rheumatoid arthritis/SLE bicuspid aortic valve (affects both the valves and the aortic root)
111
what are chronic aortic root causes of aortic regurg
bicuspid aortic valve (affects both the valves and the aortic root) spondylarthropathies (e.g. ankylosing spondylitis) hypertension syphilis Marfan's, Ehler-Danlos syndrome
112
what are acute aortic root causes of aortic regurg
aortic dissection
113
what are features of aortic regurg
early diastolic murmur: intensity of the murmur is increased by the handgrip manoeuvre collapsing pulse wide pulse pressure Quincke's sign (nailbed pulsation) De Musset's sign (head bobbing) mid-diastolic Austin-Flint murmur in severe AR - due to partial closure of the anterior mitral valve cusps caused by the regurgitation streams
114
how do you investigate aortic regurg
echocardiography
115
how do you manage aortic regurg
medical management of associated heart failure surgery for symptomatic patients or asymptomatic with LV dysfunction
116
how do thiazide diuretics work
inhibiting sodium reabsorption at the beginning of the distal convoluted tubule (DCT) by blocking the thiazide-sensitive Na+-Clˆ’ symporter
117
what are side effects of thiazide diuretics
dehydration postural hypotension hypokalaemia due to increased delivery of sodium to the distal part of the distal convoluted tubule → increased sodium reabsorption in exchange for potassium and hydrogen ions hyponatraemia hypercalcaemia the flip side of this is hypocalciuria, which may be useful in reducing the incidence of renal stones gout impaired glucose tolerance impotence thrombocytopaenia agranulocytosis photosensitivity rash pancreatitis
118
when is cardioversion used for Afib
if patient is unstable electrical or pharmacological cardioversion as an elective procedure where a rhythm control strategy is preferred.
119
how is cardioversion used when patient has Afib
synchronised to R wave to prevent delivery of a shock during the vulnerable period of cardiac repolarisation when ventricular fibrillation can be induced
120
how do you manage Afib
<48 hours - patient is heparinised, put on lifelong anticoagulants if they have risk factors otherwise can be cardioverted using electrical 'DC' cardioversion or pharmacologically with amiodarone >48 hours - anticoags given for >3 weeks prior to cardioversion or do a transoesophageal echo to exclude left atrial appendage thrombus then anticoags for >4 weeks
121
what are features of Hypertrophic obstructive cardiomyopathy (HOCM)
often asymptomatic exertional dyspnoea angina syncope typically following exercise due to subaortic hypertrophy of the ventricular septum, resulting in functional aortic stenosis sudden death (most commonly due to ventricular arrhythmias), arrhythmias, heart failure jerky pulse, large 'a' waves, double apex beat systolic murmurs ejection systolic murmur: due to left ventricular outflow tract obstruction. Increases with Valsalva manoeuvre and decreases on squatting pansystolic murmur: due to systolic anterior motion of the mitral valve → mitral regurgitation
122
What echo findings do you see in HOCM
MR SAM ASH mitral regurgitation (MR) systolic anterior motion (SAM) of the anterior mitral valve leaflet asymmetric hypertrophy (ASH)
123
What ecg changes do you see in HOCM
left ventricular hypertrophy non-specific ST segment and T-wave abnormalities, progressive T wave inversion may be seen deep Q waves atrial fibrillation may occasionally be seen
124
what investigation do you do for cardiac tamponade
echo
125
which valve is most commonly affected in infective endocarditis
mitral valve (tricuspid in IVDU)
126
What is the most common cause of infective endocarditis for 1)all patients 2)dental patients 3)<2 months after prosthetic valve surgery
1 - staph aureus 2 - staph viridans 3 - staph epidermidis
127
how do you manage hypothermia
Removing the patient from the cold environment and removing any wet/cold clothing, Warming the body with blankets Securing the airway and monitoring breathing, If the patient is not responding well to passive warming, you may consider maintaining circulation using warm IV fluids or applying forced warm air directly to the patient's body
128
You warm a patient with hypothermia but they go into shock, what happened?
rapid rewarming
129
What are features of constrictive pericarditis
dyspnoea right heart failure: elevated JVP, ascites, oedema, hepatomegaly JVP shows prominent x and y descent pericardial knock - loud S3 Kussmaul's sign is positive
130
what do you see on xray of constrictive pericarditis
pericardial calcification
131
What are features of rheumatic fever
Recent sore throat, rash, arthritis, murmur → ?rheumatic fever erythema marginatum Sydenham's chorea: this is often a late feature polyarthritis carditis and valvulitis (eg, pancarditis) subcutaneous nodules
132
how do you manage rheumatic fever
oral penicillin V NSAIDs
133
what other investigation should you always do with PE
xray to exclude pneumothorax, pleural effusion etc
134
how do you manage HOCM
Amiodarone Beta-blockers or verapamil for symptoms Cardioverter defibrillator Dual chamber pacemaker Endocarditis prophylaxis*
135
what drugs do you avoid in HOCM
nitrates ACE-inhibitors inotropes
136
what are features of coarctation of the aorta
infancy: heart failure adult: hypertension radio-femoral delay mid systolic murmur, maximal over the back apical click from the aortic valve notching of the inferior border of the ribs (due to collateral vessels) is not seen in young children
137
how do we investigate palpitations
12 lead ecg tfts for thyrotoxicosis u's and e's - potassium FBC then you want to capture episodic arrythmias using Holter monitoring if no abnormality found, can do external loop recorder or implantable loop recorder
138
What is adenosine most commonly used for?
A: Adenosine is most commonly used to terminate supraventricular tachycardias.
139
Q: Which agents enhance the effects of adenosine?
A: The effects of adenosine are enhanced by dipyridamole (antiplatelet agent).
140
Q: Which agents block the effects of adenosine?
A: The effects of adenosine are blocked by theophyllines.
141
Q: Why should adenosine be avoided in asthmatics?
A: Adenosine should be avoided in asthmatics due to possible bronchospasm.
142
Q: What is the mechanism of action of adenosine?
A: Adenosine causes transient heart block in the AV node by acting as an agonist of the A1 receptor in the atrioventricular node, inhibiting adenylyl cyclase, reducing cAMP, and causing hyperpolarization by increasing outward potassium flux.
143
Q: How long is the half-life of adenosine?
A: The half-life of adenosine is about 8-10 seconds.
144
Q: How should adenosine be administered due to its short half-life?
A: Adenosine should ideally be infused via a large-calibre cannula due to its short half-life.
145
Q: What are some adverse effects of adenosine?
A: Adverse effects of adenosine include chest pain, bronchospasm, transient flushing, and enhanced conduction down accessory pathways, resulting in increased ventricular rate (e.g., WPW syndrome).
146
Q: What is the 1st line antiplatelet treatment for acute coronary syndrome (medically treated)?
A: Aspirin (lifelong) & ticagrelor (12 months).
147
Q: What is the 2nd line antiplatelet treatment for acute coronary syndrome if aspirin is contraindicated?
A: Clopidogrel (lifelong).
148
Q: What is the 1st line antiplatelet treatment for percutaneous coronary intervention?
A: Aspirin (lifelong) & prasugrel or ticagrelor (12 months).
149
Q: What is the 2nd line antiplatelet treatment for percutaneous coronary intervention if aspirin is contraindicated?
A: Clopidogrel (lifelong).
150
Q: What is the 1st line antiplatelet treatment for TIA?
A: Clopidogrel (lifelong).
151
Q: What is the 2nd line antiplatelet treatment for TIA if clopidogrel is contraindicated or not tolerated?
A: Aspirin (lifelong) & dipyridamole (lifelong).
152
Q: What is the 1st line antiplatelet treatment for ischaemic stroke?
A: Clopidogrel (lifelong).
153
Q: What is the 2nd line antiplatelet treatment for ischaemic stroke if clopidogrel is contraindicated or not tolerated?
A: Aspirin (lifelong) & dipyridamole (lifelong).
154
Q: What is the 1st line antiplatelet treatment for peripheral arterial disease?
A: Clopidogrel (lifelong).
155
Q: What is the 2nd line antiplatelet treatment for peripheral arterial disease if clopidogrel is contraindicated or not tolerated?
A: Aspirin (lifelong).
156
Q: What is aortic dissection?
A: Aortic dissection is a rare but serious cause of chest pain characterized by a tear in the tunica intima of the wall of the aorta.
157
Q: What is the most important risk factor for aortic dissection?
A: Hypertension.
158
Q: What are some conditions associated with aortic dissection?
A: Hypertension, trauma, bicuspid aortic valve, Marfan's syndrome, Ehlers-Danlos syndrome, Turner's syndrome, Noonan's syndrome, pregnancy, and syphilis.
159
Q: How is the chest/back pain in aortic dissection typically described?
A: The pain is typically severe, sharp, and tearing in nature, and it is maximal at onset.
160
Q: What type of pain is more common in type A dissection versus type B dissection?
A: Chest pain is more common in type A dissection, while upper back pain is more common in type B dissection.
161
Q: What are some pulse-related features of aortic dissection?
A: Pulse deficit (weak or absent carotid, brachial, or femoral pulse) and variation in systolic blood pressure (>20 mmHg) between the arms.
162
Q: What are some complications of aortic dissection involving specific arteries?
A: Coronary arteries can lead to angina, spinal arteries can lead to paraplegia, and distal aorta can lead to limb ischemia.
163
Q: What are the typical ECG findings in aortic dissection?
A: The majority of patients have no or non-specific ECG changes, but a minority may show ST-segment elevation in the inferior leads.
164
Q: Describe the Stanford classification of aortic dissection.
A: Type A involves the ascending aorta (2/3 of cases) and Type B involves the descending aorta, distal to the left subclavian origin (1/3 of cases).
165
Q: Describe the DeBakey classification of aortic dissection.
A: Type I originates in the ascending aorta and propagates to at least the aortic arch and possibly beyond; Type II originates in and is confined to the ascending aorta; Type III originates in the descending aorta, rarely extends proximally but will extend distally.
166
Q: What chest X-ray finding is associated with aortic dissection?
A: Widened mediastinum.
167
Q: What is the investigation of choice for aortic dissection in stable patients?
A: CT angiography of the chest, abdomen, and pelvis.
168
Q: What key finding on CT angiography helps diagnose aortic dissection?
A: A false lumen.
169
Q: Which investigation is more suitable for unstable patients with aortic dissection?
A: Transoesophageal echocardiography (TOE).
170
Q: What is the management for type A aortic dissection?
A: Surgical management, with blood pressure controlled to a target systolic of 100-120 mmHg while awaiting intervention.
171
Q: What is the management for type B aortic dissection?
A: Conservative management, including bed rest and blood pressure reduction with IV labetalol.
172
Q: What are the complications of a backward tear in aortic dissection?
A: Aortic incompetence/regurgitation and myocardial infarction (often with an inferior pattern due to right coronary involvement).
173
Q: What are the complications of a forward tear in aortic dissection?
A: Unequal arm pulses and blood pressure, stroke, and renal failure.
174
Q: What are the clinical features of symptomatic aortic stenosis?
A: Chest pain, dyspnoea, syncope/presyncope (e.g., exertional dizziness), and murmur.
175
Q: What type of murmur is classically seen in aortic stenosis and how does it radiate?
A: An ejection systolic murmur (ESM) that classically radiates to the carotids and is decreased following the Valsalva manoeuvre.
176
Q: What are the features of severe aortic stenosis?
A: Narrow pulse pressure, slow rising pulse, delayed ESM, soft/absent S2, S4, thrill, duration of murmur, and left ventricular hypertrophy or failure.
177
Q: What is the most common cause of aortic stenosis in older patients (>65 years)?
A: Degenerative calcification.
178
Q: What is the most common cause of aortic stenosis in younger patients (<65 years)?
A: Bicuspid aortic valve.
179
Q: When should valve replacement be considered in aortic stenosis?
A: If symptomatic or if asymptomatic with a valvular gradient > 40 mmHg and features such as left ventricular systolic dysfunction.
180
Q: What are the options for aortic valve replacement (AVR)?
A: Surgical AVR, transcatheter AVR (TAVR), and balloon valvuloplasty.
181
Q: Which type of AVR is the treatment of choice for young, low/medium operative risk patients?
A: Surgical AVR.
182
Q: When is transcatheter AVR (TAVR) typically used?
A: For patients with a high operative risk.
183
Q: What is arrhythmogenic right ventricular cardiomyopathy (ARVC)?
A: ARVC, also known as arrhythmogenic right ventricular dysplasia (ARVD), is an inherited cardiovascular disease that may present with syncope or sudden cardiac death and is the second most common cause of sudden cardiac death in the young after hypertrophic cardiomyopathy.
184
Q: What is the inheritance pattern of ARVC?
A: Autosomal dominant with variable expression.
185
Q: What happens to the right ventricular myocardium in ARVC?
A: It is replaced by fatty and fibrofatty tissue.
186
Q: What are the common presentations of ARVC?
A: Palpitations, syncope, and sudden cardiac death.
187
Q: What are the typical ECG findings in ARVC?
A: T wave inversion in V1-3 and an epsilon wave, which is a terminal notch in the QRS complex, found in about 50% of those with ARVC.
188
Q: What echocardiographic changes might be seen in ARVC?
A: Subtle changes in the early stages, but may show an enlarged, hypokinetic right ventricle with a thin free wall.
189
Q: What are the management options for ARVC?
A: Drugs (sotalol), catheter ablation to prevent ventricular tachycardia, and implantable cardioverter-defibrillator (ICD).
190
Q: What is the most common sustained cardiac arrhythmia?
A: Atrial fibrillation (AF).
191
Q: What is the most important aspect of managing patients with AF?
A: Reducing the increased risk of stroke.
192
Q: How is AF classified?
A: First detected episode, paroxysmal, persistent, or permanent.
193
Q: What is paroxysmal AF?
A: AF that terminates spontaneously and lasts less than 7 days (typically < 24 hours).
194
Q: What is persistent AF?
A: AF that is not self-terminating and usually lasts greater than 7 days.
195
Q: What is permanent AF?
A: Continuous AF that cannot be cardioverted or when attempts to do so are deemed inappropriate.
196
Q: What are the symptoms of AF?
A: Palpitations, dyspnoea, and chest pain.
197
Q: What investigation is essential to diagnose AF?
A: ECG (electrocardiogram).
198
Q: What are the two key parts of managing AF?
A: Rate/rhythm control and reducing stroke risk.
199
Q: What is the aim of rate control in AF management?
A: To slow the rate down to avoid negative effects on cardiac function while accepting an irregular pulse.
200
Q: What is the aim of rhythm control in AF management?
A: To get the patient back into, and maintain, normal sinus rhythm through cardioversion.
201
Q: What is the first-line treatment for rate control in AF?
A: A beta-blocker or a rate-limiting calcium channel blocker (e.g., diltiazem).
202
Q: What combination therapy does NICE recommend if one drug does not adequately control the rate in AF?
A: Any 2 of the following: a beta-blocker, diltiazem, digoxin.
203
Q: When is rhythm control considered in AF management?
A: For specific situations such as coexistent heart failure, first onset AF, or if there is an obvious reversible cause, and if symptoms/heart rate fail to settle with rate control.
204
Q: Why is it important to anticoagulate patients before attempting cardioversion?
A: To reduce the risk of embolism leading to stroke when the patient switches from AF to sinus rhythm.
205
Q: What does a CHA2DS2-VASc score of 0 indicate for anticoagulation?
A: No treatment.
206
Q: What does a CHA2DS2-VASc score of 1 indicate for anticoagulation in males and females?
A: Males: Consider anticoagulation; Females: No treatment (score of 1 is due to gender).
207
Q: What does a CHA2DS2-VASc score of 2 or more indicate for anticoagulation?
A: Offer anticoagulation.
208
Q: What anticoagulation options does NICE recommend for AF patients?
A: Warfarin and novel oral anticoagulants (NOACs).
209
Question: What should be ensured if a CHA2DS2-VASc score suggests no need for anticoagulation?
Answer: A transthoracic echocardiogram should be done to exclude valvular heart disease, which is an absolute indication for anticoagulation.
210
Question: What is the ORBIT scoring system used for in AF?
Answer: The ORBIT scoring system is used to assess bleeding risk before starting anticoagulation.
211
Question: What does the ORBIT score indicate about bleeding risk?
0-2: Low risk (2.4 bleeds per 100 patient-years) 3: Medium risk (4.7 bleeds per 100 patient-years) 4-7: High risk (8.1 bleeds per 100 patient-years)
212
Question: Which anticoagulants are recommended by NICE for reducing stroke risk in AF?
Answer: Apixaban, dabigatran, edoxaban, and rivaroxaban.
213
Question: What is the current first-line anticoagulant for AF, and why?
Answer: Direct oral anticoagulants (DOACs) are the first-line choice because they do not require regular INR monitoring.
214
Question: When is warfarin used in AF treatment?
Answer: Warfarin is used second-line, in patients where a DOAC is contraindicated or not tolerated.
215
Question: Is aspirin recommended for reducing stroke risk in AF?
Answer: No, aspirin is not recommended for reducing stroke risk in patients with AF.
216
Question: Why is it important to recognise and treat atrial fibrillation (AF) in patients who have had a stroke or TIA?
Answer: Atrial fibrillation is a key risk factor for ischemic stroke, and recognizing and treating it is essential for reducing the risk of future strokes.
217
Question: What should be excluded before starting anticoagulation or antiplatelet therapy following a stroke or TIA?
Answer: A haemorrhage should be excluded before starting any anticoagulation or antiplatelet therapy.
218
Question: What anticoagulation options does NICE recommend for long-term stroke prevention in patients with AF following a stroke or TIA?
Answer: NICE recommends warfarin or a direct thrombin or factor Xa inhibitor for long-term stroke prevention.
219
Question: When should anticoagulation therapy be started following a TIA?
Answer: Anticoagulation for AF should start immediately following a TIA, once imaging has excluded haemorrhage.
220
Question: When should anticoagulation therapy be started following an acute stroke?
Answer: Anticoagulation therapy should be started 2 weeks after an acute stroke, in the absence of haemorrhage. Antiplatelet therapy should be given in the intervening period.
221
Question: When should the initiation of anticoagulation be delayed following a stroke?
Answer: Anticoagulation should be delayed if imaging shows a very large cerebral infarction.
222
Question: What should be done if a patient presents acutely with atrial fibrillation (AF) and has signs of haemodynamic instability?
Answer: The patient should be electrically cardioverted, following the peri-arrest tachycardia guidelines.
223
Question: How is the management of atrial fibrillation (AF) determined in haemodynamically stable patients?
If AF has been present for < 48 hours: rate or rhythm control is used. If AF has been present for ≥ 48 hours or the onset is uncertain: rate control is used. For long-term rhythm control, delay cardioversion until the patient has been maintained on therapeutic anticoagulation for at least 3 weeks.
224
Question: When should rate control be offered as the first-line treatment strategy for atrial fibrillation (AF)?
Answer: Rate control should be the first-line strategy except for patients who: Have a reversible cause for AF. Have heart failure primarily caused by AF. Have new-onset AF (< 48 hours). Have atrial flutter suitable for ablation to restore sinus rhythm. For whom rhythm control is more appropriate based on clinical judgement.
225
Question: What medications are commonly used to control heart rate in patients with atrial fibrillation (AF)?
Beta-blockers (contraindicated in asthma). Calcium channel blockers. Digoxin (not first-line due to less effectiveness during exercise, only used if physical exercise is minimal or other options are contraindicated, may be used if heart failure is coexistent).
226
Question: What medications are used for rhythm control in atrial fibrillation (AF)?
Beta-blockers. Dronedarone (second-line after cardioversion). Amiodarone (especially if coexisting heart failure).
227
Question: When should catheter ablation be considered in atrial fibrillation (AF) management?
Answer: Catheter ablation is recommended for patients who have not responded to or wish to avoid antiarrhythmic medications.
228
Question: What is the goal of catheter ablation in atrial fibrillation (AF)?
Answer: The goal is to ablate the faulty electrical pathways causing AF, typically due to aberrant electrical activity between the pulmonary veins and left atrium.
229
Question: What are the key technical aspects of catheter ablation in AF?
Answer: The procedure is performed percutaneously, typically via the groin. Radiofrequency (using heat) or cryotherapy can be used to ablate the tissue.
230
Question: When should anticoagulation therapy be used in patients undergoing catheter ablation for atrial fibrillation (AF)?
Answer: Anticoagulation should be used 4 weeks before and during the procedure.
231
Question: Does catheter ablation reduce the stroke risk in atrial fibrillation (AF) patients?
Answer: No, catheter ablation controls the rhythm but does not reduce stroke risk. Patients still require anticoagulation according to their CHA2DS2-VASc score.
232
Question: What is the recommended duration of anticoagulation after catheter ablation for atrial fibrillation (AF)?
If CHA2DS2-VASc score = 0: 2 months of anticoagulation is recommended. If CHA2DS2-VASc score > 1: long-term anticoagulation is recommended.
233
Question: What are notable complications of catheter ablation for atrial fibrillation (AF)?
Cardiac tamponade. Stroke. Pulmonary vein stenosis.
234
Question: What is the most common primary cardiac tumour?
Answer: Atrial myxoma.
235
Question: Where do most atrial myxomas occur?
Answer: 75% occur in the left atrium, most commonly attached to the fossa ovalis.
236
Question: In which gender are atrial myxomas more common?
Answer: Atrial myxomas are more common in females.
237
Question: What systemic symptoms can be seen in a patient with atrial myxoma?
Dyspnoea Fatigue Weight loss Pyrexia of unknown origin Clubbing
238
Question: What complications can occur due to atrial myxoma?
Answer: Emboli.
239
Question: What heart rhythm disturbance is commonly seen in atrial myxoma?
Answer: Atrial fibrillation.
240
Question: What characteristic heart sound might be heard in a patient with atrial myxoma?
Answer: A mid-diastolic murmur, often described as a "tumour plop."
241
Question: What does an echocardiogram typically show in a patient with atrial myxoma?
Answer: A pedunculated, heterogeneous mass typically attached to the fossa ovalis region of the interatrial septum.
242
Question: What is the most common congenital heart defect found in adulthood?
Answer: Atrial septal defects (ASDs).
243
Question: What are the two types of atrial septal defects (ASDs)?
Answer: Ostium secundum and ostium primum.
244
Question: Which type of atrial septal defect (ASD) is the most common?
Answer: Ostium secundum.
245
Question: What characteristic heart murmur is heard in patients with an atrial septal defect (ASD)?
Answer: An ejection systolic murmur with fixed splitting of S2.
246
Question: What complication can occur in patients with atrial septal defects (ASDs) related to embolism?
Answer: Embolism may pass from the venous system to the left side of the heart, potentially causing a stroke.
247
Question: What is heart block (atrioventricular (AV) block)?
Answer: Heart block is impaired electrical conduction between the atria and ventricles.
248
Question: How many types of atrioventricular (AV) block are there?
Answer: There are three types: First-degree heart block Second-degree heart block (Type 1 and Type 2) Third-degree (complete) heart block
249
Question: What is characteristic of first-degree heart block?
Answer: The PR interval is > 0.2 seconds. Asymptomatic first-degree heart block is relatively common and does not need treatment.
250
Question: What is characteristic of second-degree heart block, type 1 (Mobitz I, Wenckebach)?
Answer: There is progressive prolongation of the PR interval until a dropped beat occurs.
251
Question: What is characteristic of second-degree heart block, type 2 (Mobitz II)?
Answer: The PR interval is constant, but the P wave is often not followed by a QRS complex.
252
Question: What is characteristic of third-degree (complete) heart block?
Answer: There is no association between the P waves and QRS complexes.
253
Question: What is B-type natriuretic peptide (BNP) and where is it produced?
Answer: BNP is a hormone produced mainly by the left ventricular myocardium in response to strain.
254
Question: What conditions can raise B-type natriuretic peptide (BNP) levels?
Answer: BNP levels can be raised in heart failure, myocardial ischaemia, valvular disease, and chronic kidney disease (due to reduced excretion).
255
Question: What factors can reduce BNP levels?
Answer: Treatment with ACE inhibitors, angiotensin-2 receptor blockers, and diuretics can reduce BNP levels.
256
Question: What are the effects of B-type natriuretic peptide (BNP)?
Vasodilation Diuretic and natriuretic effects Suppression of sympathetic tone and the renin-angiotensin-aldosterone system
257
Question: What is a clinical use of B-type natriuretic peptide (BNP)?
Answer: BNP is used in diagnosing patients with acute dyspnoea. A BNP level < 100 pg/ml makes heart failure unlikely, but raised levels should prompt further investigation to confirm the diagnosis.
258
Question: What are beta-blockers primarily used for?
Answer: Beta-blockers are mainly used in the management of cardiovascular disorders.
259
Question: What are the indications for beta-blocker use?
Angina Post-myocardial infarction Heart failure (certain beta-blockers improve symptoms and mortality) Arrhythmias (used for rate control in atrial fibrillation) Hypertension (role has diminished in recent years) Thyrotoxicosis Migraine prophylaxis Anxiety
260
Question: What are the common side effects of beta-blockers?
Bronchospasm Cold peripheries Fatigue Sleep disturbances (including nightmares) Erectile dysfunction
261
Question: What are the contraindications for using beta-blockers?
Uncontrolled heart failure Asthma Sick sinus syndrome Concurrent use with verapamil (may precipitate severe bradycardia)
262
Question: What is Brugada syndrome?
Answer: Brugada syndrome is an inherited cardiovascular disease that may present with sudden cardiac death. It is inherited in an autosomal dominant fashion and has an estimated prevalence of 1:5,000-10,000. It is more common in Asians.
263
Question: What are the characteristic ECG changes in Brugada syndrome?
Convex ST segment elevation > 2mm in > 1 of V1-V3 followed by a negative T wave Partial right bundle branch block
264
Question: How can the ECG changes in Brugada syndrome be made more apparent?
Answer: The ECG changes may become more apparent following the administration of flecainide or ajmaline, which is the investigation of choice in suspected cases of Brugada syndrome.
265
Question: What is the management for Brugada syndrome?
Answer: Implantable cardioverter-defibrillator (ICD).
266
Question: With what is Buerger's disease strongly associated?
Answer: Smoking.
267
Question: What are the features of Buerger's disease?
Extremity ischaemia Intermittent claudication Ischaemic ulcers Superficial thrombophlebitis Raynaud's phenomenon
268
Question: Which cardiac enzyme rises first after myocardial infarction?
Answer: Myoglobin.
269
Question: Which cardiac enzyme is useful for detecting reinfarction and why?
Answer: CK-MB, because it returns to normal after 2-3 days, whereas troponin T remains elevated for up to 10 days.
270
Question: What cardiac markers have largely superseded the use of various cardiac enzymes in diagnosing myocardial infarction?
Answer: Troponin T and Troponin I.
271
Question: What are the key points about Hypertrophic Obstructive Cardiomyopathy?
Leading cause of sudden cardiac death in young athletes Usually due to a mutation in the gene encoding β-myosin heavy chain protein Common cause of sudden death Echo findings include mitral regurgitation (MR), systolic anterior motion (SAM) of the anterior mitral valve, and asymmetric septal hypertrophy
272
Question: What are the key points about Arrhythmogenic Right Ventricular Dysplasia (ARVD)?
Right ventricular myocardium is replaced by fatty and fibrofatty tissue Around 50% of patients have a mutation in genes encoding components of desmosome ECG abnormalities in V1-3, typically T wave inversion. An epsilon wave is found in about 50% of those with ARVD, described as a terminal notch in the QRS complex
273
Question: What are the classic causes of Dilated Cardiomyopathy?
Alcohol Coxsackie B virus Wet beriberi Doxorubicin
274
Question: What are the classic causes of Restrictive Cardiomyopathy?
Amyloidosis Post-radiotherapy Loeffler's endocarditis
275
Question: What is Peripartum Cardiomyopathy and when does it typically develop?
Answer: Peripartum cardiomyopathy typically develops between the last month of pregnancy and 5 months post-partum. It is more common in older women, those with greater parity, and multiple gestations.
276
Question: What is Takotsubo Cardiomyopathy and its typical presentation?
Also known as "stress-induced cardiomyopathy" Often occurs after a stressful event, such as finding out a family member has died Patients develop chest pain and features of heart failure Characterized by transient, apical ballooning of the myocardium Treatment is supportive
277
Question: What are the characteristic exam features of a Myocardial Infarction?
Heavy, central chest pain that may radiate to the neck and left arm Nausea, sweating Elderly patients and diabetics may experience no pain Risk factors for cardiovascular disease
278
Question: What are the characteristic exam features of a Pneumothorax?
History of asthma, Marfan's syndrome, etc. Sudden dyspnoea and pleuritic chest pain
279
Question: What are the characteristic exam features of a Pulmonary Embolism?
Sudden dyspnoea and pleuritic chest pain Calf pain/swelling Current combined pill user, malignancy
280
Question: What are the characteristic exam features of Pericarditis?
Sharp pain relieved by sitting forwards May be pleuritic in nature
281
Question: What are the characteristic exam features of a Dissecting Aortic Aneurysm?
'Tearing' chest pain radiating through to the back Unequal upper limb blood pressure
282
Question: What are the characteristic exam features of Gastro-oesophageal Reflux Disease (GERD)?
Burning retrosternal pain Other possible symptoms include regurgitation and dysphagia
283
Question: What are the characteristic exam features of Musculoskeletal Chest Pain?
Pain often worse on movement or palpation May be precipitated by trauma or coughing
284
Question: What are the characteristic exam features of Shingles?
Answer: Pain often precedes the rash
285
Question: What is Aortic Dissection, and how is it diagnosed and treated?
Occurs when blood tracks into the medial layer of the aorta, creating a false lumen Presents with tearing intrascapular pain Most common in Afro-Caribbean males aged 50-70 Diagnosis suggested by widened mediastinum on chest X-ray and confirmed by CT angiography Type A lesions (proximal) treated surgically, Type B lesions (distal) managed non-operatively
286
Question: What are the typical presenting features and diagnostic methods for a Pulmonary Embolism?
Sudden onset of chest pain, haemoptysis, hypoxia, and small pleural effusions Underlying deep vein thrombosis ECG findings: S waves in lead I, Q waves in lead III, and inverted T waves in lead III Diagnosed by CT pulmonary angiography Treatment with anticoagulation, possible thrombolysis in severe cases
287
Question: What are the typical presenting features and diagnostic methods for a Myocardial Infarction?
Sudden onset of central, crushing chest pain radiating to the neck and left arm Atypical presentations in the elderly and diabetics Diagnosed by dynamic ECG changes and cardiac enzyme changes Treatment with oral antiplatelet agents, primary coronary angioplasty, and/or thrombolysis
288
Question: What are the presenting features and treatment for a Perforated Peptic Ulcer?
Sudden onset of epigastric abdominal pain, followed by generalized abdominal pain Erect chest X-ray may show free intra-abdominal air Treatment usually with laparotomy, small defects excised and overlaid with an omental patch, larger defects managed with partial gastrectomy
289
Question: What is Boerhaave's Syndrome, and how is it diagnosed and treated?
Spontaneous rupture of the oesophagus due to severe vomiting Presents with sudden onset of severe chest pain Severe sepsis secondary to mediastinitis Diagnosed by CT contrast swallow Treatment with thoracotomy and lavage; primary repair if < 12 hours, T-tube for controlled fistula if > 12 hours
290
Question: What role do loop diuretics play in heart failure management according to the NICE guidelines?
Answer: Loop diuretics, such as furosemide, are important for managing fluid overload but have not demonstrated a long-term reduction in mortality.
291
Question: What is the first-line treatment for all patients with heart failure?
Answer: The first-line treatment is both an ACE inhibitor and a beta-blocker. Generally, one drug should be started at a time, based on clinical judgement.
292
Question: Which beta-blockers are licensed to treat heart failure in the UK?
Answer: Bisoprolol, carvedilol, and nebivolol are the beta-blockers licensed to treat heart failure in the UK.
293
Question: Do ACE inhibitors and beta-blockers affect mortality in heart failure with preserved ejection fraction?
Answer: No, ACE inhibitors and beta-blockers have no effect on mortality in heart failure with preserved ejection fraction.
294
Question: What is the standard second-line treatment for heart failure according to NICE guidelines?
Answer: The standard second-line treatment is an aldosterone antagonist (mineralocorticoid receptor antagonist), such as spironolactone or eplerenone.
295
Question: What should be monitored when a patient is on both ACE inhibitors and aldosterone antagonists?
Answer: Potassium levels should be monitored due to the risk of hyperkalaemia.
296
Question: What role do SGLT-2 inhibitors play in heart failure management?
Answer: SGLT-2 inhibitors, such as canagliflozin, dapagliflozin, and empagliflozin, reduce glucose reabsorption and increase urinary glucose excretion. They have been shown to reduce hospitalisation and cardiovascular death in heart failure with reduced ejection fraction.
297
Question: When should third-line treatment for heart failure be initiated and by whom?
Answer: Third-line treatment should be initiated by a specialist.
298
Question: What are the criteria for using ivabradine in heart failure?
Answer: Ivabradine is indicated if the patient is in sinus rhythm with a heart rate > 75/min and has a left ventricular ejection fraction < 35%.
299
Question: What is the role of digoxin in heart failure management?
Answer: Digoxin has not been proven to reduce mortality in heart failure but may improve symptoms due to its inotropic properties. It is strongly indicated if there is coexistent atrial fibrillation.
300
Question: What are the indications for cardiac resynchronisation therapy in heart failure?
Answer: Indications include a widened QRS complex on ECG, such as left bundle branch block.
301
Question: What vaccines should be offered to patients with heart failure?
Answer: Patients should be offered an annual influenza vaccine and a one-off pneumococcal vaccine. Adults with asplenia, splenic dysfunction, or chronic kidney disease need a booster every 5 years.
302
Question: What is the New York Heart Association (NYHA) classification used for?
Answer: The NYHA classification is used to classify the severity of heart failure.
303
Question: What are the characteristics of NYHA Class I heart failure?
No symptoms No limitation: ordinary physical exercise does not cause undue fatigue, dyspnoea, or palpitations
304
Question: What are the characteristics of NYHA Class II heart failure?
Mild symptoms Slight limitation of physical activity: comfortable at rest but ordinary activity results in fatigue, palpitations, or dyspnoea
305
Question: What are the characteristics of NYHA Class III heart failure?
Moderate symptoms Marked limitation of physical activity: comfortable at rest but less than ordinary activity results in symptoms
306
Question: What are the characteristics of NYHA Class IV heart failure?
Severe symptoms Unable to carry out any physical activity without discomfort: symptoms of heart failure are present even at rest with increased discomfort with any physical activity
307
Question: What is the most common form of cardiomyopathy?
Answer: Dilated cardiomyopathy (DCM), accounting for 90% of cases.
308
Question: What is the most common cause of dilated cardiomyopathy?
Answer: Idiopathic.
309
Question: Name some infectious causes of dilated cardiomyopathy.
Answer: Myocarditis (e.g., Coxsackie B, HIV, diphtheria, Chagas disease).
310
Question: What are some non-infectious causes of dilated cardiomyopathy?
Answer: Ischaemic heart disease, peripartum, hypertension, iatrogenic (e.g., doxorubicin), substance abuse (e.g., alcohol, cocaine), inherited conditions (e.g., Duchenne muscular dystrophy), infiltrative diseases (e.g., haemochromatosis, sarcoidosis), nutritional deficiencies (e.g., wet beriberi).
311
Question: What is the inheritance pattern for most genetic predispositions to dilated cardiomyopathy?
Answer: The majority of defects are inherited in an autosomal dominant fashion, although other patterns of inheritance are seen.
312
Question: What is the pathophysiology of dilated cardiomyopathy?
Answer: Dilated heart leading to predominantly systolic dysfunction. All four chambers are dilated, but the left ventricle is more so than the right ventricle. Eccentric hypertrophy (sarcomeres added in series) is seen.
313
Question: What are the classic clinical features of dilated cardiomyopathy?
Answer: Classic findings of heart failure, systolic murmur (due to stretching of the valves resulting in mitral and tricuspid regurgitation), S3 heart sound, 'balloon' appearance of the heart on chest x-ray.
314
Question: What is the ECG criterion for diagnosing left ventricular hypertrophy (LVH)?
Answer: The sum of the S wave in V1 and the R wave in V5 or V6 exceeds 40 mm.
315
Question: What is the ECG criterion for diagnosing right ventricular hypertrophy (RVH)?
Answer: The criterion for right ventricular hypertrophy is not explicitly given in the prompt. However, RVH can often be identified by a right axis deviation and tall R waves in the right precordial leads (V1 and V2).
316
Question: What are the ECG features of left atrial enlargement (LAE)?
Bifid P wave in lead II with a duration > 120 ms. In V1, the P wave has a negative terminal portion.
317
Question: What are the ECG features of right atrial enlargement (RAE)?
Tall P waves in both lead II and V1 which exceed 0.25 mV.
318
Question: What are the causes of left axis deviation (LAD)?
Left anterior hemiblock Left bundle branch block Inferior myocardial infarction Wolff-Parkinson-White syndrome with a right-sided accessory pathway Hyperkalaemia Congenital conditions such as ostium primum ASD and tricuspid atresia Minor LAD in obese people
319
Question: What are the causes of right axis deviation (RAD)?
Right ventricular hypertrophy Left posterior hemiblock Lateral myocardial infarction Chronic lung disease leading to cor pulmonale Pulmonary embolism Ostium secundum ASD Wolff-Parkinson-White syndrome with a left-sided accessory pathway Normal in infants under 1 year old Minor RAD in tall people
320
Question: What are the ECG features of digoxin toxicity?
Down-sloping ST depression (referred to as 'reverse tick' or 'scooped out') Flattened or inverted T waves Shortened QT interval Arrhythmias such as AV block and bradycardia
321
Question: What are the typical ECG features and common causes of left bundle branch block (LBBB)?
ECG Features: WiLLiaM Pattern: 'W' shape in lead V1 'M' shape in lead V6 Wide QRS complexes (>120 ms) Causes: Myocardial infarction: Diagnosing MI in patients with existing LBBB is challenging. The Sgarbossa criteria can help diagnose MI in the presence of LBBB. Hypertension Aortic stenosis Cardiomyopathy Rare causes: Idiopathic fibrosis Digoxin toxicity Hyperkalaemia Note: New LBBB is always considered pathological and warrants further investigation.
322
Question: What ECG changes are considered normal variants in athletes?
ECG Changes Considered Normal Variants in Athletes: Sinus Bradycardia A slower than normal heart rate (<60 bpm) due to high vagal tone. Junctional Rhythm Rhythm originating from the atrioventricular (AV) junction, often seen during rest or sleep. First-Degree Heart Block Prolonged PR interval (>200 ms) but with each P wave followed by a QRS complex. Mobitz Type 1 (Wenckebach Phenomenon) Progressive prolongation of the PR interval until a P wave is not followed by a QRS complex (dropped beat).
323
Question: What are the causes of a prolonged PR interval and in which condition is a short PR interval seen?
Causes of a Prolonged PR Interval: Idiopathic Ischaemic heart disease Digoxin toxicity Hypokalaemia (more common association) Rheumatic fever Aortic root pathology (e.g., abscess secondary to endocarditis) Lyme disease Sarcoidosis Myotonic dystrophy Athletes (as a normal variant) Note: Hyperkalaemia can rarely cause a prolonged PR interval, but it is a much less common association compared to hypokalaemia. Condition Associated with a Short PR Interval: Wolff-Parkinson-White syndrome
324
Question: What are the common causes of right bundle branch block (RBBB) and how can you differentiate it from left bundle branch block (LBBB) on an ECG?
Differentiating RBBB from LBBB: Mnemonic: WiLLiaM MaRRoW LBBB: 'W' in V1 and 'M' in V6 RBBB: 'M' in V1 and 'W' in V6 Causes of Right Bundle Branch Block (RBBB): Normal variant (more common with increasing age) Right ventricular hypertrophy Chronically increased right ventricular pressure (e.g., cor pulmonale) Pulmonary embolism Myocardial infarction Atrial septal defect (ostium secundum) Cardiomyopathy or myocarditis
325
Question: What is Eisenmenger's syndrome?
Answer: Eisenmenger's syndrome describes the reversal of a left-to-right shunt in a congenital heart defect due to pulmonary hypertension. This occurs when an uncorrected left-to-right shunt leads to remodeling of the pulmonary microvasculature, eventually causing obstruction to pulmonary blood flow and pulmonary hypertension.
326
Question: Which congenital heart defects are associated with Eisenmenger's syndrome?
Ventricular septal defect (VSD) Atrial septal defect (ASD) Patent ductus arteriosus (PDA)
327
Question: What are the clinical features of Eisenmenger's syndrome?
Original murmur may disappear Cyanosis Clubbing Right ventricular failure Haemoptysis Embolism
328
Question: What is the management for Eisenmenger's syndrome?
Answer: Heart-lung transplantation is required.
329
Question: How does Eisenmenger's syndrome develop from a congenital heart defect?
Answer: Eisenmenger's syndrome develops when a left-to-right shunt caused by a congenital heart defect is left uncorrected. This leads to remodeling of the pulmonary microvasculature, increased pulmonary vascular resistance, and ultimately, pulmonary hypertension, reversing the shunt to right-to-left.
330
Question: What happens to the original murmur in Eisenmenger's syndrome?
Answer: The original murmur may disappear in Eisenmenger's syndrome.
331
Question: Why does cyanosis occur in Eisenmenger's syndrome?
Answer: Cyanosis occurs in Eisenmenger's syndrome due to the reversal of the shunt from left-to-right to right-to-left, leading to deoxygenated blood entering the systemic circulation.
332
Question: What are the signs of right ventricular failure seen in Eisenmenger's syndrome?
Answer: Signs of right ventricular failure in Eisenmenger's syndrome include cyanosis, clubbing, and haemoptysis.
333
Question: Why is heart-lung transplantation required for Eisenmenger's syndrome?
Answer: Heart-lung transplantation is required for Eisenmenger's syndrome because of the severe pulmonary hypertension and the irreversible damage to the pulmonary vasculature.
334
Question: What is Acute Heart Failure (AHF)?
Answer: Acute Heart Failure (AHF) is a life-threatening emergency characterized by the sudden onset or worsening of heart failure symptoms, which can present with or without a history of pre-existing heart failure. AHF without a past history of heart failure is called de-novo AHF.
335
Question: What is de-novo Acute Heart Failure?
Answer: De-novo Acute Heart Failure refers to AHF occurring without a past history of heart failure, often caused by increased cardiac filling pressures and myocardial dysfunction, usually as a result of ischemia, which reduces cardiac output and causes hypoperfusion and pulmonary edema.
336
Question: What are common causes of de-novo Acute Heart Failure?
Answer: Common causes of de-novo AHF include: Ischemia Viral myopathy Toxins Valve dysfunction
337
Question: What is decompensated Acute Heart Failure?
Answer: Decompensated Acute Heart Failure is a more common form of AHF that occurs in patients with a background history of heart failure. It often presents with signs of fluid congestion, weight gain, orthopnea, and breathlessness.
338
Question: What are the most common precipitating causes of decompensated Acute Heart Failure?
Acute coronary syndrome Hypertensive crisis Acute arrhythmia Valvular disease
339
Question: How are patients with Acute Heart Failure categorized?
Answer: Patients with AHF are broadly characterized into one of four groups based on their presentation: With or without hypoperfusion With or without fluid congestion This classification is clinically useful for determining the therapeutic approach.
340
Question: What are the common symptoms and signs of Acute Heart Failure?
Symptoms: Breathlessness Reduced exercise tolerance Edema Fatigue Signs: Cyanosis Tachycardia Elevated jugular venous pressure Displaced apex beat Chest signs: bibasal crackles or wheeze S3 heart sound
341
Question: What percentage of patients with Acute Heart Failure have a normal or increased blood pressure?
Answer: Over 90% of patients with AHF have a normal or increased blood pressure.
342
Question: What are the components of the diagnostic workup for Acute Heart Failure?
Blood tests: To identify underlying abnormalities such as anemia, abnormal electrolytes, or infection. Chest X-ray: To detect pulmonary venous congestion, interstitial edema, and cardiomegaly. Echocardiogram: Recommended for new-onset heart failure or suspected changes in cardiac function. B-type natriuretic peptide (BNP): Raised levels (>100 mg/litre) indicate myocardial damage and support the diagnosis.
343
Question: What are the chest X-ray findings in patients with Acute Heart Failure?
Answer: Chest X-ray findings in AHF include pulmonary venous congestion, interstitial edema, and cardiomegaly.
344
Question: What is a common respiratory symptom of chronic heart failure?
Answer: Dyspnoea (shortness of breath).
345
Question: What type of cough is associated with chronic heart failure?
Answer: A cough that may be worse at night and associated with pink/frothy sputum.
346
Question: What term describes shortness of breath that occurs when lying flat in chronic heart failure patients?
Answer: Orthopnoea.
347
Question: What is paroxysmal nocturnal dyspnoea?
Answer: It is a sudden onset of severe shortness of breath at night that awakens the patient from sleep.
348
Question: What is 'cardiac wheeze'?
Answer: A wheezing sound associated with chronic heart failure due to pulmonary congestion.
349
Question: What is cardiac cachexia?
Answer: Weight loss seen in chronic heart failure patients, occurring in up to 15% of patients, and may be hidden by weight gained due to oedema.
350
Question: What might be heard on chest examination in a patient with chronic heart failure?
Answer: Bibasal crackles.
351
Question: What are the signs of right-sided heart failure?
Raised jugular venous pressure (JVP) Ankle oedema Hepatomegaly
352
Question: What is the first-line treatment for all patients with acute heart failure?
Answer: IV loop diuretics (e.g. furosemide or bumetanide).
353
Question: What is the recommended oxygen saturation target for patients with acute heart failure?
Answer: 94-98%, in line with British Thoracic Society guidelines.
354
Question: When might nitrates be used in the management of acute heart failure?
Answer: Nitrates may be used if there is concomitant myocardial ischaemia, severe hypertension, or regurgitant aortic or mitral valve disease.
355
Question: What is the major side effect/contraindication of nitrate use in acute heart failure?
Answer: Hypotension.
356
Question: What treatment is recommended for patients with acute heart failure and respiratory failure?
Answer: Continuous positive airway pressure (CPAP).
357
Question: What is a key consideration in the management of acute heart failure with hypotension or cardiogenic shock?
Answer: Some treatments for acute heart failure (e.g., loop diuretics and nitrates) may exacerbate hypotension.
358
Question: Which inotropic agent might be used for patients with severe left ventricular dysfunction and potentially reversible cardiogenic shock?
Answer: Dobutamine.
359
Question: Under what circumstances should beta-blockers be stopped in patients with acute heart failure?
Answer: Beta-blockers should only be stopped if the patient has a heart rate less than 50 beats per minute, second or third degree atrioventricular block, or shock.
360
Question: How is heart failure defined?
Answer: Heart failure is defined as a clinical syndrome where the heart is unable to pump enough blood to meet the metabolic needs of the body, usually due to structural or functional heart disease.
361
Question: What are the two main types of heart failure based on ejection fraction?
Heart failure with reduced ejection fraction (HF-rEF), typically defined as LVEF < 35-40%. Heart failure with preserved ejection fraction (HF-pEF), where LVEF is normal or near-normal.
362
Question: What is the typical cause of systolic dysfunction?
Answer: Systolic dysfunction is typically caused by conditions such as ischaemic heart disease, dilated cardiomyopathy, myocarditis, and arrhythmias.
363
Question: What is the typical cause of diastolic dysfunction?
Answer: Diastolic dysfunction is typically caused by conditions such as hypertrophic obstructive cardiomyopathy, restrictive cardiomyopathy, cardiac tamponade, and constrictive pericarditis.
364
Question: How is heart failure typically described in terms of time?
Answer: Heart failure is typically described as acute or chronic. Acute heart failure often refers to an acute exacerbation of chronic heart failure.
365
Question: What are the most urgent symptoms of acute heart failure?
Answer: The most urgent symptoms of acute heart failure are often due to left ventricular failure, resulting in pulmonary oedema.
366
Question: What are the common features of left ventricular failure?
Answer: Common features of left ventricular failure include pulmonary oedema, dyspnoea, orthopnoea, paroxysmal nocturnal dyspnoea, and bibasal fine crackles.
367
Question: What are the common features of right ventricular failure?
Answer: Common features of right ventricular failure include peripheral oedema, ankle/sacral oedema, raised jugular venous pressure, hepatomegaly, weight gain due to fluid retention, and anorexia ('cardiac cachexia').
368
Question: What is high-output heart failure?
Answer: High-output heart failure refers to a situation where a 'normal' heart is unable to pump enough blood to meet the metabolic needs of the body.
369
Question: What are some causes of high-output heart failure?
Answer: Causes of high-output heart failure include anaemia, arteriovenous malformation, Paget's disease, pregnancy, thyrotoxicosis, and thiamine deficiency (wet Beri-Beri).
370
Question: What causes right-sided heart failure?
Answer: Right-sided heart failure is caused by increased right ventricular afterload (e.g. pulmonary hypertension) or increased right ventricular preload (e.g. tricuspid regurgitation).
371
Question: What condition is associated with a short PR interval?
Answer: Wolff-Parkinson-White syndrome is associated with a short PR interval.
372
Question: What causes the first heart sound (S1)?
Answer: The first heart sound (S1) is caused by the closure of the mitral and tricuspid valves.
373
Question: When is the first heart sound (S1) soft?
Answer: The first heart sound (S1) is soft if there is a long PR interval or mitral regurgitation.
374
Question: When is the first heart sound (S1) loud?
Mitral stenosis Left-to-right shunts Short PR interval, atrial premature beats Hyperdynamic states
375
Question: What causes the second heart sound (S2)?
Answer: The second heart sound (S2) is caused by the closure of the aortic and pulmonary valves.
376
Question: When is the second heart sound (S2) soft?
Answer: The second heart sound (S2) is soft in aortic stenosis.
377
Question: What is normal regarding the splitting of the second heart sound (S2)?
Answer: Splitting of the second heart sound (S2) during inspiration is normal.
378
Question: What causes the third heart sound (S3)?
Answer: The third heart sound (S3) is caused by the diastolic filling of the ventricle.
379
Question: In which conditions is the third heart sound (S3) heard?
Answer: The third heart sound (S3) is heard in left ventricular failure (e.g., dilated cardiomyopathy), constrictive pericarditis (called a pericardial knock), and mitral regurgitation.
380
Question: When is the third heart sound (S3) considered normal?
Answer: The third heart sound (S3) is considered normal if the individual is under 30 years old (may persist in women up to 50 years old).
381
Question: What causes the fourth heart sound (S4)?
Answer: The fourth heart sound (S4) is caused by atrial contraction against a stiff ventricle.
382
Question: In which conditions can the fourth heart sound (S4) be heard?
Answer: The fourth heart sound (S4) may be heard in aortic stenosis, hypertrophic obstructive cardiomyopathy (HOCM), and hypertension.
383
Question: How is the fourth heart sound (S4) related to the ECG?
Answer: The fourth heart sound (S4) coincides with the P wave on an ECG.
384
Question: What unique physical finding is associated with S4 in hypertrophic obstructive cardiomyopathy (HOCM)?
Answer: In hypertrophic obstructive cardiomyopathy (HOCM), a double apical impulse may be felt as a result of a palpable S4.
385
Answer: Causes of a loud second heart sound (S2) include:
Hypertension: systemic (loud A2) or pulmonary (loud P2) Hyperdynamic states Atrial septal defect without pulmonary hypertension
386
Question: What are the causes of a widely split second heart sound (S2)?
Causes of a widely split second heart sound (S2) include: Deep inspiration Right bundle branch block (RBBB) Pulmonary stenosis Severe mitral regurgitation
387
Question: What are the causes of a reversed (paradoxical) split second heart sound (S2), where P2 occurs before A2?
Causes of a reversed (paradoxical) split second heart sound (S2) include: Left bundle branch block (LBBB) Severe aortic stenosis Right ventricular pacing Wolff-Parkinson-White (WPW) syndrome type B (causes early P2) Patent ductus arteriosus
388
Question: How does NICE define hypertension?
NICE defines hypertension as: A clinic reading persistently above ≥ 140/90 mmHg, or A 24-hour blood pressure average reading ≥ 135/85 mmHg
389
Question: What are some renal causes of secondary hypertension?
Glomerulonephritis Chronic pyelonephritis Adult polycystic kidney disease Renal artery stenosis
390
Question: What are some endocrine causes of secondary hypertension?
Primary hyperaldosteronism Phaeochromocytoma Cushing's syndrome Liddle's syndrome Congenital adrenal hyperplasia (11-beta hydroxylase deficiency) Acromegaly
391
Question: What are some other causes of secondary hypertension?
Glucocorticoids NSAIDs Pregnancy Coarctation of the aorta Combined oral contraceptive pill
392
Question: What investigations are recommended for patients with newly diagnosed hypertension?
Fundoscopy: to check for hypertensive retinopathy Urine dipstick: to check for renal disease ECG: to check for left ventricular hypertrophy or ischaemic heart disease
393
Question: What tests are typically performed following a hypertension diagnosis?
24-hour blood pressure monitoring Urea and electrolytes HbA1c (for diabetes mellitus) Lipid profile (for hyperlipidaemia) ECG Urine dipstick
394
Question: What are the common drugs used to treat hypertension and their mechanisms and side effects?
ACE inhibitors: Inhibit conversion of angiotensin I to angiotensin II. Common side effects include cough, angioedema, and hyperkalaemia. First-line treatment in younger patients (< 55 years old). Calcium channel blockers: Block voltage-gated calcium channels, relaxing vascular smooth muscle. Common side effects include flushing, ankle swelling, and headache. First-line treatment in older patients (≥ 55 years old). Thiazide diuretics: Inhibit sodium absorption at the beginning of the distal convoluted tubule. Common side effects include hyponatraemia, hypokalaemia, and dehydration. Angiotensin II receptor blockers (A2RB): Block effects of angiotensin II at the AT1 receptor. Common side effects include hyperkalaemia. Used when patients do not tolerate ACE inhibitors due to cough.
395
Question: According to the 2008 NICE guidelines, which procedures do NOT require antibiotic prophylaxis for infective endocarditis?
Dental procedures Upper and lower gastrointestinal tract procedures Genitourinary tract procedures, including urological, gynecological, and obstetric procedures and childbirth Upper and lower respiratory tract procedures, including ear, nose, and throat procedures and bronchoscopy
396
Question: What does the jugular venous pulse (JVP) provide information about?
Answer: The jugular venous pulse provides information about right atrial pressure and can offer clues to underlying valvular disease.
397
Question: What is Kussmaul's sign, and in what condition is it observed?
Answer: Kussmaul's sign describes a paradoxical rise in JVP during inspiration, seen in constrictive pericarditis.
398
Question: What are cannon 'a' waves, and when are they seen?
Answer: Cannon 'a' waves are caused by atrial contractions against a closed tricuspid valve. They are seen in complete heart block, ventricular tachycardia/ectopics, nodal rhythm, and single-chamber ventricular pacing.
399
Question: What does the 'v' wave in the JVP represent, and when are giant 'v' waves observed?
Answer: The 'v' wave represents passive filling of blood into the atrium against a closed tricuspid valve. Giant 'v' waves are observed in tricuspid regurgitation.
400
Question: What is mitral regurgitation (MR)?
Answer: Mitral regurgitation (MR) occurs when blood leaks back through the mitral valve during systole, leading to reduced efficiency of the heart as less blood is pumped with each contraction.
401
Question: What is the second most common valve disease after aortic stenosis?
Answer: Mitral regurgitation (MR) is the second most common valve disease after aortic stenosis.
402
Question: What are the risk factors for developing mitral regurgitation?
Female sex Lower body mass Age Renal dysfunction Prior myocardial infarction (MI) Prior mitral stenosis or valve prolapse Collagen disorders (e.g., Marfan's Syndrome, Ehlers-Danlos syndrome)
403
Question: What are some common causes of mitral regurgitation?
Coronary artery disease (CAD) or post-MI Mitral valve prolapse Infective endocarditis Rheumatic fever (less common in developed countries) Congenital causes
404
Question: Are most patients with mitral regurgitation symptomatic or asymptomatic?
Answer: Most patients with MR are asymptomatic, especially those with mild to moderate MR. Symptoms, if present, are often due to left ventricular failure, arrhythmias, or pulmonary hypertension.
405
Question: What symptoms may patients with severe mitral regurgitation experience?
Answer: Patients with severe MR may experience fatigue, shortness of breath, and edema.
406
Question: What does the murmur of mitral regurgitation sound like, and where is it heard?
Answer: The murmur of MR is typically a pansystolic murmur described as "blowing" and is best heard at the apex, radiating into the axilla.
407
Question: What are the findings on auscultation for severe mitral regurgitation?
Answer: In severe MR, S1 may be quiet due to incomplete closure of the valve, and S2 may be widely split.
408
Question: What are the treatment options for acute mitral regurgitation?
Nitrates, diuretics, positive inotropes, and intra-aortic balloon pump to increase cardiac output.
409
Question: What are the key investigations for mitral regurgitation?
ECG: May show a broad P wave (atrial enlargement) Chest X-ray: May show cardiomegaly with an enlarged left atrium and ventricle Echocardiography: Crucial for diagnosis and assessing the severity of MR
410
Question: What medications are considered for chronic mitral regurgitation in heart failure?
Answer: In heart failure, ACE inhibitors, beta-blockers, and spironolactone may be considered for chronic MR.
411
Question: What is the treatment approach for acute, severe mitral regurgitation?
Answer: In acute, severe MR, surgery is indicated. Valve repair is preferred over replacement due to better outcomes. If repair is not possible, valve replacement with an artificial or pig valve is considered.
412
Question: What is the most common cause of death following a myocardial infarction (MI)?
Answer: The most common cause of death following MI is cardiac arrest, usually due to ventricular fibrillation.
413
Question: What is cardiogenic shock, and what causes it after MI?
Answer: Cardiogenic shock occurs when a large portion of the ventricular myocardium is damaged, resulting in decreased ejection fraction. It is often difficult to treat and may require inotropic support or an intra-aortic balloon pump.
414
Question: What is the role of medications in managing chronic heart failure following MI?
Answer: In chronic heart failure following MI, loop diuretics (e.g., furosemide) are used to reduce fluid overload, while ACE inhibitors and beta-blockers improve long-term prognosis.
415
Question: What arrhythmias are common after a myocardial infarction?
Common arrhythmias following MI include: Ventricular fibrillation (most common cause of death) Ventricular tachycardia Bradyarrhythmias such as atrioventricular block (especially after inferior MI)
416
Question: What is the typical presentation of pericarditis following a myocardial infarction?
Pericarditis within the first 48 hours of a transmural MI is common, presenting with: Chest pain (worse when lying flat) Pericardial rub on auscultation Pericardial effusion (detected on echocardiogram)
417
Question: What is Dressler's syndrome, and when does it typically occur after an MI?
Dressler's syndrome occurs 2-6 weeks after MI and is thought to be an autoimmune reaction. It presents with: Fever Pleuritic pain Pericardial effusion Raised ESR It is treated with NSAIDs.
418
Question: What is a left ventricular aneurysm and how is it related to MI?
Answer: A left ventricular aneurysm occurs when ischemic damage weakens the myocardium, leading to aneurysm formation. It is typically associated with persistent ST elevation and left ventricular failure. Thrombus may form in the aneurysm, increasing the risk of stroke, so anticoagulation is often required.
419
Question: What is left ventricular free wall rupture, and how is it managed?
Answer: Left ventricular free wall rupture occurs in about 3% of MI patients, typically 1-2 weeks after MI. It presents with acute heart failure and cardiac tamponade (raised JVP, pulsus paradoxus, diminished heart sounds). Urgent pericardiocentesis and thoracotomy are required.
420
Question: What is a ventricular septal defect following MI, and how is it diagnosed and treated?
Answer: A ventricular septal defect (VSD) can occur within the first week after MI, causing acute heart failure and a pan-systolic murmur. It is diagnosed by echocardiography and requires urgent surgical correction.
421
Question: What causes acute mitral regurgitation after MI, and how is it managed?
Answer: Acute mitral regurgitation following MI is more common with infero-posterior infarctions and may be due to ischemia or rupture of the papillary muscle. It presents with acute hypotension and pulmonary edema, and requires vasodilator therapy and often emergency surgical repair.
422
Question: What is myocarditis?
Answer: Myocarditis is the inflammation of the myocardium, which can have a variety of underlying causes. It should be particularly considered in younger patients who present with chest pain.
423
Question: What are the common causes of myocarditis?
Common causes of myocarditis include: Viral: Coxsackie B, HIV Bacterial: Diphtheria, Clostridia Spirochaetes: Lyme disease Protozoa: Chagas' disease, Toxoplasmosis Autoimmune diseases Drugs: Doxorubicin
424
Question: What are the typical symptoms of myocarditis?
The typical presentation includes: Young patient with acute history Chest pain Dyspnoea Arrhythmias
425
Question: What blood tests are useful in diagnosing myocarditis?
Blood tests commonly show: Elevated inflammatory markers (99% of cases) Elevated cardiac enzymes Elevated BNP
426
Question: What are the ECG findings in myocarditis?
ECG findings in myocarditis include: Tachycardia Arrhythmias ST/T wave changes, such as ST-segment elevation and T wave inversion
427
Question: How is myocarditis managed?
Management of myocarditis includes: Treating the underlying cause (e.g., antibiotics for bacterial infections) Supportive care for heart failure or arrhythmias
428
Question: What are the potential complications of myocarditis?
Complications of myocarditis include: Heart failure Arrhythmias, which may lead to sudden death Dilated cardiomyopathy, usually a late complication
429
Question: What is orthostatic hypotension?
Answer: Orthostatic hypotension is a condition characterized by a significant drop in blood pressure (usually >20/10 mm Hg) within three minutes of standing, leading to symptoms such as presyncope or syncope.
430
Question: Who is more at risk for orthostatic hypotension?
Orthostatic hypotension is more common in: Older individuals Patients with neurodegenerative diseases (e.g., Parkinson's disease) Patients with diabetes or hypertension
431
Question: What are some iatrogenic causes of orthostatic hypotension?
Iatrogenic causes include: Alpha-blockers (e.g., used for benign prostatic hyperplasia)
432
Question: What are the common features of orthostatic hypotension?
Features of orthostatic hypotension include: A drop in blood pressure (>20/10 mm Hg) within three minutes of standing Presyncope or syncope
433
Question: What is the management of orthostatic hypotension?
Treatment options for orthostatic hypotension include: Midodrine (a vasopressor) Fludrocortisone (a corticosteroid that increases blood volume)
434
Question: What defines postural hypotension?
Answer: Postural hypotension is defined as a fall in systolic blood pressure > 20 mmHg on standing.
435
Question: What are the causes of postural hypotension?
Hypovolaemia (e.g., dehydration, blood loss) Autonomic dysfunction (e.g., diabetes, Parkinson's disease) Drugs: Diuretics Antihypertensives L-dopa (used in Parkinson's disease) Phenothiazines (antipsychotics) Antidepressants Sedatives Alcohol consumption
436
Question: What is pulsus paradoxus and what conditions are associated with it?
Pulsus paradoxus is a greater than normal (>10 mmHg) fall in systolic blood pressure during inspiration, causing a faint or absent pulse during inspiration. It is commonly seen in: Severe asthma Cardiac tamponade
437
Question: What is a slow-rising/plateau pulse and which condition is it associated with?
Answer: A slow-rising/plateau pulse is characterized by a gradual increase in the pulse, often associated with aortic stenosis.
438
Question: What is a collapsing pulse and what conditions are associated with it?
Answer: A collapsing pulse is a pulse that rises quickly and falls abruptly. It is associated with: Aortic regurgitation Patent ductus arteriosus Hyperkinetic states (e.g., anaemia, thyrotoxicosis, fever, exercise, pregnancy)
439
Question: What is pulsus alternans and what condition is it associated with?
Answer: Pulsus alternans is characterized by a regular alternation of the force of the arterial pulse, and it is commonly seen in severe left ventricular failure (LVF).
440
Question: What is a bisferiens pulse and what condition is it associated with?
Answer: A bisferiens pulse is a 'double pulse' with two systolic peaks. It is commonly associated with mixed aortic valve disease.
441
Question: What is a jerky pulse and what condition is it associated with?
Answer: A jerky pulse is a quick, abrupt rise and fall in pulse force, and it is typically associated with hypertrophic obstructive cardiomyopathy (HOCM).
442
Question: What is the general definition of supraventricular tachycardia (SVT) and what are its most common types?
Answer: SVT refers to any tachycardia that originates above the ventricles. It is often used to describe paroxysmal SVT, characterized by sudden onset of narrow complex tachycardia. Common types include: Atrioventricular nodal re-entry tachycardia (AVNRT) Atrioventricular re-entry tachycardia (AVRT) Junctional tachycardias
443
Question: What is the initial acute management of supraventricular tachycardia (SVT)?
Vagal manoeuvres: Valsalva manoeuvre (e.g., blowing into an empty plastic syringe) Carotid sinus massage Intravenous adenosine: Rapid IV bolus: 6mg If unsuccessful, give 12mg, then 18mg if needed Contraindicated in asthmatics, in which case verapamil is preferred Electrical cardioversion (if the above methods fail)
444
Question: What are the preventative treatments for supraventricular tachycardia (SVT)?
Beta-blockers Radio-frequency ablation
445
Question: What is the definition of syncope?
Answer: Syncope is a transient loss of consciousness caused by global cerebral hypoperfusion, with rapid onset, short duration, and spontaneous complete recovery. It excludes other causes of collapse, such as epilepsy.
446
Question: What are the main types of syncope according to the European Society of Cardiology guidelines (2009)?
Reflex syncope (neurally mediated): Vasovagal: Triggered by emotion, pain, or stress Situational: Triggered by specific actions like cough, micturition, or gastrointestinal issues Carotid sinus syncope Orthostatic syncope: Primary autonomic failure: e.g., Parkinson's, Lewy body dementia Secondary autonomic failure: e.g., diabetic neuropathy, amyloidosis, uraemia Drug-induced: e.g., diuretics, alcohol, vasodilators Volume depletion: e.g., haemorrhage, diarrhoea Cardiac syncope: Arrhythmias: Bradycardias (sinus node dysfunction, AV conduction disorders) or tachycardias (supraventricular, ventricular) Structural causes: e.g., valvular disease, myocardial infarction, hypertrophic obstructive cardiomyopathy Others: e.g., pulmonary embolism
447
Question: Which type of syncope is the most common across all age groups?
Answer: Reflex syncope (neurally mediated) is the most common cause of syncope in all age groups, although orthostatic and cardiac causes become more common in older patients.
448
Question: What is involved in the evaluation of a patient with syncope?
Cardiovascular examination Postural blood pressure readings: A symptomatic fall in systolic BP > 20 mmHg, diastolic BP > 10 mmHg, or a decrease in systolic BP < 90 mmHg is diagnostic of orthostatic syncope. ECG for all patients Other tests depending on clinical features Patients with typical features, no postural drop, and a normal ECG do not require further investigations
449
Question: What is Torsades de Pointes?
Answer: Torsades de Pointes is a form of polymorphic ventricular tachycardia associated with a long QT interval. It may deteriorate into ventricular fibrillation, leading to sudden death.
450
Question: What are the causes of a long QT interval that can lead to Torsades de Pointes?
Answer: Causes of long QT interval include: Congenital: Jervell-Lange-Nielsen syndrome Romano-Ward syndrome Antiarrhythmics: e.g., amiodarone, sotalol, class 1a antiarrhythmic drugs Medications: Tricyclic antidepressants Antipsychotics Chloroquine Terfenadine Erythromycin Electrolyte disturbances: Hypocalcaemia Hypokalaemia Hypomagnesaemia Other causes: Myocarditis Hypothermia Subarachnoid haemorrhage
451
Question: What is the first-line treatment for Torsades de Pointes?
Answer: The first-line treatment for Torsades de Pointes is IV magnesium sulphate.
452
Question: What are the signs of Tricuspid Regurgitation?
Signs of Tricuspid Regurgitation include: Pan-systolic murmur Prominent/giant V waves in the JVP Pulsatile hepatomegaly Left parasternal heave
453
Question: What are the causes of Tricuspid Regurgitation?
Causes of Tricuspid Regurgitation include: Right ventricular infarction Pulmonary hypertension (e.g., COPD) Rheumatic heart disease Infective endocarditis (especially in intravenous drug users) Ebstein's anomaly Carcinoid syndrome
454
Question: What is Ventricular Tachycardia (VT), and what are its types?
Answer: Ventricular Tachycardia (VT) is a broad-complex tachycardia originating from a ventricular ectopic focus. It can lead to ventricular fibrillation and requires urgent treatment. The two main types of VT are: Monomorphic VT: Most commonly caused by myocardial infarction. Polymorphic VT: Includes torsades de pointes, which is caused by a prolonged QT interval.
455
Question: What are the causes of a prolonged QT interval that can precipitate polymorphic VT (including torsades de pointes)?
Answer: Causes of a prolonged QT interval include: Congenital: Jervell-Lange-Nielsen syndrome (includes deafness, due to abnormal potassium channels) Romano-Ward syndrome (no deafness) Drugs: Amiodarone, sotalol, class 1a antiarrhythmic drugs Tricyclic antidepressants, fluoxetine Chloroquine, terfenadine, erythromycin Other: Electrolyte imbalances (e.g., hypocalcaemia, hypokalaemia, hypomagnesaemia) Acute myocardial infarction Myocarditis Hypothermia Subarachnoid haemorrhage
456
Question: What is the management for Ventricular Tachycardia (VT)?
Answer: If the patient has adverse signs (e.g., systolic BP < 90 mmHg, chest pain, heart failure), immediate cardioversion is indicated. In the absence of adverse signs, antiarrhythmics can be used. If these fail, synchronised electrical cardioversion may be needed. Drug Therapy: Amiodarone: Ideally administered through a central line. Lidocaine: Use with caution in severe left ventricular impairment. Procainamide: Another option. Important: Verapamil should NOT be used in VT. If drug therapy fails: Electrophysiological study (EPS). Implantable cardioverter-defibrillator (ICD): Particularly indicated in patients with significantly impaired LV function.
457
Question: What is Wolff-Parkinson-White (WPW) syndrome, and what causes it?
Answer: WPW syndrome is caused by a congenital accessory conducting pathway between the atria and ventricles, leading to atrioventricular re-entry tachycardia (AVRT). This pathway bypasses the normal AV node conduction, which allows rapid conduction and can cause atrial fibrillation (AF), which may degenerate rapidly into ventricular fibrillation (VF).
458
Question: What are the key ECG features of Wolff-Parkinson-White (WPW) syndrome?
Short PR interval Wide QRS complexes with a slurred upstroke, called the 'delta wave' Left axis deviation if the accessory pathway is right-sided Right axis deviation if the accessory pathway is left-sided
459
Question: How do you differentiate between type A and type B WPW?
Type A (left-sided pathway): Dominant R wave in V1. Type B (right-sided pathway): No dominant R wave in V1.
460
Question: What are the common associations with Wolff-Parkinson-White (WPW) syndrome?
Hypertrophic obstructive cardiomyopathy (HOCM) Mitral valve prolapse Ebstein's anomaly Thyrotoxicosis Secundum atrial septal defect (ASD)
461
Question: What is the management for Wolff-Parkinson-White (WPW) syndrome?
Definitive treatment: Radiofrequency ablation of the accessory pathway. Medical therapy: Sotalol, amiodarone, flecainide. Caution: Sotalol should be avoided in patients with coexistent atrial fibrillation (AF), as it may prolong the refractory period at the AV node, increasing the rate of transmission through the accessory pathway, leading to potential ventricular fibrillation (VF).
462
When cant you take statins
pregnancy macrolides
463
if doing fibrinolysis for STEMI, what do you give
alteplase and fondaparinux
464
What scoring system is used to see if a PE patient can be managed as an outpatient
Pulmonary Embolism Severity Index (PESI) score
465
What drug should you avoid in VT
verapamil
466
Q: What is the management for major bleeding (e.g., variceal hemorrhage, intracranial hemorrhage) in a patient on warfarin?
Stop warfarin. Give intravenous vitamin K 5mg. Administer prothrombin complex concentrate or fresh frozen plasma (FFP) if prothrombin complex concentrate is not available.
467
Q: What should be done if the INR is greater than 8.0 with minor bleeding in a patient on warfarin?
Stop warfarin. Give intravenous vitamin K 1-3mg. Repeat the dose of vitamin K if the INR is still too high after 24 hours. Restart warfarin when the INR is less than 5.0.
468
Q: What is the recommended action if the INR is greater than 8.0 without bleeding in a patient on warfarin?
Stop warfarin. Give vitamin K 1-5mg by mouth (using the intravenous preparation orally). Repeat the dose of vitamin K if the INR is still too high after 24 hours. Restart warfarin when the INR is less than 5.0.
469
Q: How should minor bleeding be managed if the INR is between 5.0 and 8.0 in a patient on warfarin?
Stop warfarin. Give intravenous vitamin K 1-3mg. Restart warfarin when the INR is less than 5.0.
470
Q: What is the management for an INR between 5.0 and 8.0 without bleeding in a patient on warfarin?
Withhold 1 or 2 doses of warfarin. Reduce the subsequent maintenance dose.
471
Q: Why is prothrombin complex concentrate preferred over fresh frozen plasma (FFP) in cases of intracranial hemorrhage?
A: Prothrombin complex concentrate is preferred because FFP can take time to defrost, whereas prothrombin complex concentrate can be administered more quickly.
472
Q: What are the two main types of prosthetic heart valves?
A: Biological (bioprosthetic) valves and mechanical valves.
473
Q: What are biological (bioprosthetic) valves typically made from?
A: They are usually bovine (cow) or porcine (pig) in origin.
474
Q: What is the major disadvantage of biological (bioprosthetic) valves?
A: Structural deterioration and calcification over time.
475
Q: At what age are most patients typically given a bioprosthetic valve?
A: Most older patients (> 65 years for aortic valves and > 70 years for mitral valves) receive a bioprosthetic valve.
476
Q: Do patients with biological valves require long-term anticoagulation?
A: Long-term anticoagulation is not usually needed, but warfarin may be given for the first 3 months depending on patient factors. Low-dose aspirin is given long-term.
477
Q: What is the most common type of mechanical valve now implanted?
A: The bileaflet valve. Ball-and-cage valves are rarely used nowadays.
478
Q: What is the major disadvantage of mechanical valves?
A: Increased risk of thrombosis, necessitating long-term anticoagulation.
479
Q: Which anticoagulant is preferred for patients with mechanical heart valves?
A: Warfarin is still used in preference to DOACs for patients with mechanical heart valves.
480
Q: According to the 2017 European Society of Cardiology guidelines, when is aspirin given to patients with mechanical valves?
A: Aspirin is given only if there is an additional indication, such as ischaemic heart disease.
481
Q: What is the target INR for patients with a mechanical aortic valve?
A: The target INR is 3.0.
482
Q: What is the target INR for patients with a mechanical mitral valve?
A: The target INR is 3.5.
483
What antithrombotic therapy is given to 1 - bioprosthetic valves and 2 - mechanical valves
bioprosthetic: aspirin mechanical: warfarin + aspirin
484
How do you manage asymptomatic mitral stenosis
monitoring - regular echocardiogram every 6-12 months
485
How should you initiate sacubitril-valsartan for heart failure management
should be initiated following ACEi or ARB wash-out period
486
What type of murmur is seen in pulmonary stenosis
ejection systolic murmur. This murmur is typically heard best in the second left intercostal space and may radiate towards the left shoulder.
487
How do you manage coarctation of aorta in a baby
IV prostaglandins to maintain PDA before corrective surgery is done
488
What are side effects of Ivabadrine
visual effects, particular luminous phenomena, are common headache bradycardia, heart block
489
What ABPM measurement matters more, daytime or night time or combined?
daytime
490
What is a contraindication to nitrates
aortic stenosis hypotension (<90) bradycardia (<50) treatment for erectile dysfunction (eg sildenafil)
491
What strep group is Streptococcus sanguinis part of
strep viridans
492
What can you add second line to heart failure after spiro
sglt2 inhibitor
493
Q: When should you refer a patient with suspected ACS to the hospital?
Current chest pain or chest pain in the last 12 hours with an abnormal ECG: emergency admission Chest pain 12-72 hours ago: refer to hospital the same-day for assessment Chest pain > 72 hours ago: perform full assessment with ECG and troponin measurement before deciding upon further action
494
Q: How does NICE define anginal pain?
Constricting discomfort in the front of the chest, or in the neck, shoulders, jaw, or arms Precipitated by physical exertion Relieved by rest or GTN in about 5 minutes
495
Q: What are the classifications of anginal pain according to NICE?
Typical angina: all 3 features present Atypical angina: 2 of the 3 features present Non-anginal chest pain: 1 or none of the features present
496
Q: What is the first-line investigation for stable angina that cannot be excluded by clinical assessment alone?
CT coronary angiography
497
Q: What is the second-line investigation for stable angina according to NICE?
Non-invasive functional imaging (looking for reversible myocardial ischaemia)
498
Q: What is the third-line investigation for stable angina?
Invasive coronary angiography
499
Q: What is Wellen's syndrome typically caused by?
A: High-grade stenosis in the left anterior descending coronary artery.
500
Q: What are the characteristics of a patient's condition at the time of presentation with Wellen's syndrome?
A: The patient's pain may have resolved, and cardiac enzymes may be normal or minimally elevated.
501
Q: What are the ECG features of Wellen's syndrome?
Biphasic or deep T wave inversion in leads V2-3 Minimal ST elevation No Q waves
502
How do we grade murmurs
The Levine Scale: Grade 1 - Very faint murmur, frequently overlooked Grade 2 - Slight murmur Grade 3 - Moderate murmur without palpable thrill Grade 4 - Loud murmur with palpable thrill Grade 5 - Very loud murmur with extremely palpable thrill. Can be heard with stethoscope edge Grade 6 - Extremely loud murmur - can be heard without stethoscope touching the chest wall
503
Which heart failure drug causes ototoxicity
IV loop diuretics
504
What anginal drug do you avoid in heart failure
verapamil
505
How many blood cultures are recommended for infective endocarditis
3 sets
506
Q: Why is the use of Amiodarone limited?
Very long half-life (20-100 days), requiring loading doses. Should ideally be given into central veins (causes thrombophlebitis). Proarrhythmic effects due to lengthening of the QT interval. Interacts with other drugs (P450 inhibitor), e.g., decreases metabolism of warfarin. Numerous long-term adverse effects.
507
Q: What should be monitored before starting Amiodarone treatment?
A: TFT (thyroid function test), LFT (liver function test), U&E (urea and electrolytes), CXR (chest X-ray).
508
Q: How often should TFT and LFT be monitored in patients taking Amiodarone?
A: Every 6 months.
509
Q: What are the adverse effects of Amiodarone?
Thyroid dysfunction (hypothyroidism and hyperthyroidism). Corneal deposits. Pulmonary fibrosis/pneumonitis. Liver fibrosis/hepatitis. Peripheral neuropathy, myopathy. Photosensitivity. 'Slate-grey' appearance. Thrombophlebitis and injection site reactions. Bradycardia. Lengthens QT interval.
510
how is adenosine given for narrow tachycardia
IV bolus
511
what do you do if fibrinolysis fails
transfer for pci
512
Q: What is another name for Kartagener's syndrome?
A: Primary ciliary dyskinesia.
513
Q: What are the key features of Kartagener's syndrome?
Dextrocardia or complete situs inversus. Bronchiectasis. Recurrent sinusitis. Subfertility (due to diminished sperm motility and defective ciliary action in the fallopian tubes).
514
Q: Why might Kartagener's syndrome be mentioned frequently in examinations?
A: Due to its association with dextrocardia, which can present as 'quiet heart sounds' and 'small volume complexes in lateral leads'.
515
Q: What mnemonic helps remember the clotting factors affected by warfarin?
A: 1972 (II, VII, IX, and X).
516
Q: For which conditions is warfarin still used as a first-line treatment?
A: Mechanical heart valves.
517
Q: What is the target INR for venous thromboembolism when using warfarin?
A: 2.5, and if recurrent, 3.5.
518
Q: What is the target INR for atrial fibrillation when using warfarin?
A: 2.5.
519
Q: Name two factors that may potentiate the effect of warfarin.
A: Liver disease and P450 enzyme inhibitors (e.g., amiodarone, ciprofloxacin).
520
Q: Name two side effects of warfarin.
A: Haemorrhage and skin necrosis.
521
Q: What is a rare but serious side effect of warfarin when it is first started?
A: Skin necrosis due to a temporary procoagulant state from reduced protein C biosynthesis.
522
Q: What syndrome may occur involving the feet due to warfarin therapy?
A: Purple toes syndrome.
523
What murmur can pulmonary hypertension cause
tricuspid regurg
524
murmur heard loudest in the second intercostal space along the left sternal border
pulmonary stenosis
525
What drugs should be stopped during c diff infection
opiods
526
What are features of mitral valve prolapse
patients may complain of atypical chest pain or palpitations mid-systolic click (occurs later if patient squatting) late systolic murmur (longer if patient standing) complications: mitral regurgitation, arrhythmias (including long QT), emboli, sudden death
527
What is mitral valve prolapse associated with
congenital heart disease: PDA, ASD cardiomyopathy Turner's syndrome Marfan's syndrome, Fragile X osteogenesis imperfecta pseudoxanthoma elasticum Wolff-Parkinson White syndrome long-QT syndrome Ehlers-Danlos Syndrome polycystic kidney disease
528
What heart defect is PKD associated with
mitral valve prolapse
529
Hyeprtensive black diabetic drug
ARB
530
How do you monitor treatment for statins
LFTs at baseline, 3 months and 12 months fasting lipid profile
531
What cardiac abnormalities are associated with carcinoid syndrome
Pulmonary stenosis and tricuspid insufficiency
532
If fibrinolysis is given for STEMI, what must you repeat after and when
ECG after 60-90 mins
533
What are risk factors for asystole in bradycardia
complete heart block with broad complex QRS recent asystole Mobitz type II AV block ventricular pause > 3 seconds
534
What artery is PCI done in
radial artery
535
in ALS, if IV access cant be done, what should you do and where from
Give via intraosseous access (proximal tibia)
536
Q: What is the suggested initial blind antibiotic therapy for native valve endocarditis?
A: Amoxicillin, consider adding low-dose gentamicin.
537
Q: What is the suggested antibiotic therapy for native valve endocarditis if the patient is penicillin allergic, has MRSA, or severe sepsis?
A: Vancomycin + low-dose gentamicin.
538
Q: What is the suggested antibiotic therapy for prosthetic valve endocarditis?
A: Vancomycin + rifampicin + low-dose gentamicin.
539
Q: What is the suggested antibiotic therapy for native valve endocarditis caused by staphylococci?
A: Flucloxacillin.
540
Q: What is the suggested antibiotic therapy for prosthetic valve endocarditis caused by staphylococci?
A: Flucloxacillin + rifampicin + low-dose gentamicin.
541
Q: What is the suggested antibiotic therapy for endocarditis caused by fully-sensitive streptococci (e.g. viridans)?
A: Benzylpenicillin.
542
Q: What are the indications for surgery in infective endocarditis?
Severe valvular incompetence Aortic abscess (often indicated by a lengthening PR interval) Infections resistant to antibiotics/fungal infections Cardiac failure refractory to standard medical treatment Recurrent emboli after antibiotic therapy
543
PAILS pneumonic for ST elevation with reciprocal changes
PAILS stands for P-posterior A-anterior I-inferior L-lateral S-septal. ST elevations in these leads most commonly create reciprocal ST depressions in the corresponding leads of the next letter in the mnemonic.
544
What CCB cant you use for rate control in AF
Amlodipine, Only non-dihydropyridine calcium channel blockers such as Verapamil can be used due to their atrioventricular node blocking actions
545
Causes of high output cardiac failure pneumonic
High-output heart failure: 2Ps, 2As, 2Ts Pregnancy and Pagets Anaemia and arteriovenous malformation Thyrotoxicosis and thiamine (wet beri-beri)
546
When using statin therapy, what dose of statin should be used
atorvastatin 20mg for primary prevention, 80mg for secondary prevention
547
What is characteristic for pacemaker on ECG
long straight lines before QRS complex
548
Pulmonary artery occlusion pressure - Low Cardiac output - Low Systemic vascular resistance - High In ITU, Diagnosis?
Hypovolaemia - Cardiac output is lowered in hypovolaemia due to decreased preload. PAP is low (therefore preload is low). Cardiac Output is also low. The main clue as to why the answer is Hypovolaemia is because PAP, and therefore preload is low, and preload is largely determined by venous blood volume. This also explains why CO is low, as if only a little amount of blood is returning to the heart, the heart can only pump that small amount of blood. and SVR is raised. The SVR is raised because in order to maintain blood pressure, the body vasoconstricts the peripheral arteries.
549
Pulmonary artery occlusion pressure - High Cardiac output - Low Systemic vascular resistance - High In ITU, Diagnosis?
Cardiogenic Shock - In cardiogenic shock pulmonary pressures are often high. This is the basis for the use of venodilators in the treatment of pulmonary oedema. PAP and SVR are raised, but CO is low, and this is just suggesting that the problem lies with the heart, therefore it is cardiogeneic shock. The heart is receiving a good amount of blood (because PAP and thus preload is raised), but because the heart isn't pumping very well, the body is vasoconstricting the peripheral vessels and so SVR is raised once again.
550
Pulmonary artery occlusion pressure - Low Cardiac output - High Systemic vascular resistance - Low In ITU, Diagnosis?
Septic Shock Decreased SVR is a major feature of sepsis. A hyperdynamic circulation is often present. This is the reason for the use of vasoconstrictors. SVR is reduced. This is typically seen in sepsis - endotoxins and the inflammatory response vasodilates the peripheries, and so SVR is low. If the peripheral essels are all loose and leaky, not much blood remains inside the vessels and so the venous blood volume will also be low, hence the preload is low, and this is indicated by the low PAP. And in response, the heart is having to work harder to get blood to the organs because not only is it receiving less blood from the venous system, but the body is also struggling to maintain a blood pressure because of the peripheral vasodilation (BP = CO x SVR). So the heart tries to increase heart rate and stroke volume (adrenergic response etc), and cardiac output is thus high.
551
What drug can make clopidogrel less effective
PPI
552
What side effect can amiodarone cause linked to hormones
thyroid dysfunction - hyperthyroidism
553
for a patient with ACS after cocaine use, what would you give
IV benzos
554